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ABSTRACT 
 
RATE-LIMITING STEP OF CONE PHOTOTRANSDUCTION RECOVERY AND 
OGUCHI DISEASE MECHANISMS 
By  
Frank Sungping Chen 
Advisor: Ching-Kang Jason Chen, Ph.D. 
 
Retinal photoreceptors provide the first gateway in which light information from the 
environment is transformed into neuronal signals. The cone and rod photoreceptors are 
responsible for day and night vision, respectively. Understanding rod and cone phototransduction 
is to figure out how these cells differ in their temporal and spatial sensitivities to allow 
perception of a broad dynamic range of stimuli. Phototransduction is mediated through a G-
protein signaling cascade. Light absorption by visual pigment triggers the isomerization of 11-
cis-retinal covalently attached to these pigments, which are heptahelical transmembrane G-
protein-coupled receptors. Isomerization of 11-cis-retinal to all-trans-retinal activates the 
receptor, which catalyzes the exchange of GDP for GTP on the α subunit of heterotrimeric G-
protein called transducin. Activated transducin relieves inhibitory constraint on cGMP-PDE, 
leading to rapid hydrolysis of cGMP, closure of cGMP gated cation channels, and membrane 
hyperpolarization. In order for photoreceptor to be responsive to light again, this robust 
phototransduction pathway must be deactivated in a timely fashion and this involves several 
reactions simultaneously. First, the activated opsin must be phosphorylated by G-protein-coupled 
receptor kinases (GRKs) and capped by arrestin binding. Second, activated transducin must 
hydrolyze bound GTP through intrinsic GTPase activity, which is accelerated by a GTPase 
accelerating protein (GAP) complex comprised of RGS9-1/Gβ5-L/R9AP. Mutations in human 
genes involved in these reactions cause various visual defects. Cone, by and large, uses the same 
set of genes for pigment and transducin deactivations but it has lower sensitivity and faster 
kinetics than rod and is responsible for high visual acuity. During phototransduction recovery in 
which multiple reactions take place, the slowest reaction will determine the overall rate of 
recovery. In rod, this so-called, rate-limiting step has been determined to be transducin 
deactivation. It is unknown whether cone transducin deactivation also controls the timing of cone 
	   xii	  
recovery, although we and others have shown that cone possesses a higher level of GAP 
concentration. In this thesis, the rate-limiting step in cone phototransduction recovery has been 
unequivocally determined by overexpressing RGS9-1 by 2.7 fold in mouse cones, which results 
in accelerated cone recovery. Complementarily, we find that ectopically expressing a human 
cone opsin kinase GRK7 in mouse cones does not affect cone recovery. These results altogether 
demonstrate that the rate-limiting step of cone recovery is the GTP-hydrolysis of cone 
transducin, not the opsin phosphorylation by GRKs. By elucidating the rate-limiting step of 
photoreceptor recovery, we have revealed the importance of G-protein cycling in timing of both 
rod and cone photoreceptors. This may further be generalized to other physiological processes 
controlled by heterotrimeric G-proteins. 
The proper shutoff of phototransduction is essential for normal vision as recovery defects 
lead to visual impairment. Even though the reaction catalyzed by GRK1 is not rate-limiting, 
mutations of this important gene render rhodopsin phosphorylation and deactivation the slowest 
step in rod recovery and create a pathological condition. GRK1 mutations have been found in 
Oguchi disease patients, who suffer from congenital stationary night blindness. One of the 
mutations, V380D, is investigated in detail in this study. Transgenic expression of GRK1 V380D 
mutant in rods reveals a kinase with reduced expression and catalytic activity. While V380D 
GRK1 is found capable of inactivating rhodopsin, the reduction in kinase activity leads to a 
delayed dark adaptation, and is congruent with the night blindness phenotype observed in Oguchi 
disease patients. Finally, we have also investigated the role of post-translational isoprenylation 
on GRK1 function. We found that isoprenylation is required for GRK1 membrane association 
and outer segment targeting. Altogether our data add significantly to understanding the structure 
and function of GRK1, which is one of the least understood molecules involved in vertebrate 
phototransduction. 
  
 
 
	  
CHAPTER 1 
Introduction 
Heterotrimeric G-protein signaling mediates the transduction of extracellular stimuli into 
intracellular responses in many physiological processes. Extracellular stimuli, such as hormones, 
odors, light, neurotransmitters, are detected by G-protein-coupled Receptors (GPCR) with 
heptahelical transmembrane motifs (Chen 2005; DeMaria and Ngai 2010). Activated GPCR 
catalyzes the exchange of GTP for GDP on the α-subunits of trimeric G-proteins, which are 
composed of α and βγ subunits. Upon activation, Gα-GTP dissociates from Gβγ subunits and 
both moieties can modulate activity of respective downstream effectors. The termination of a G-
protein signaling pathway requires the shutoff of GPCR and deactivation of activated G-proteins, 
the latter of which is mediated by intrinsic GTPase activity of Gα subunits that turns bound GTP 
into GDP. The shutoff of GPCR requires phosphorylation of its C-terminal Ser/Thr residues by 
G-protein-coupled receptor Kinases (GRKs) (Doan, Mendez et al. 2006). GPCR phosphorylation 
dampens its catalytic activity toward G-protein but complete uncoupling between the two is not 
achieved until the binding of arrestin to phosphorylated GPCR. (Premont and Gainetdinov 2007; 
Ribas, Penela et al. 2007). The intrinsic GTPase activity, which is necessary for turning off 
activated G-protein, is regulated by GTPase accelerating proteins (GAP) (Siderovski and Willard 
2005). In rod phototransduction, a prototypical G-protein signaling pathway, the duration of 
rhodopsin signaling is determined not by GPCR lifetime but by how fast Gα subunit hydrolyzes 
bound GTP (Krispel, Chen et al. 2006). Genetic defects in G-protein deactivation are relatively 
rare, but in a few established cases they are accompanied by severe pathological consequences 
(Spiegel 2000; Lamb and Pugh 2004; Nishiguchi, Sandberg et al. 2004; Lania, Mantovani et al. 
2006; Conn, Ulloa-Aguirre et al. 2007). 
Phototransduction 
 Vision, the ability to perceive light, is one of the sensory abilities for living organisms 
(Figure 1.1). The conversion of photon into electrical signal takes place at photoreceptor outer 
segment, which lies between the outer nuclear layer (ONL) of the retina and retinal pigmented 
epithelium (RPE) (Burns and Arshavsky 2005; Chen 2005; Fu and Yau 2007; Larhammar, 
Nordstrom et al. 2009). Two types of image forming photoreceptors, rod and cone, are found in 
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the outer retina. A third type of light sensitive cells, intrinsically light-sensitive retinal ganglion 
cells (ipRGC) are found in the inner retina. Rod is responsible for dim light vision and cone is 
responsible for daylight vision, whereas ipRGC is essential for transmitting non-image forming 
visual functions (Provencio, Jiang et al. 1998; Fu, Zhong et al. 2005; Sedwick 2010). Image 
forming photoreceptors have four distinct morphological structures: outer segment (OS), inner 
segment (IS), cell body, and synaptic terminal. For rod, light absorption occurs at the disc 
membranes of the OS, which contains millions of photon capturing molecules called rhodopsin. 
Rhodopsin consistes of an apo-protein called opsin and a chromophore, 11-cis-retinal, which is 
covalently attached to Lys296 residue through an Schiff base linkage. The chromophore acts as 
an inverse agonist that keeps rhodopsin inactive. In the dark, cyclic GMP (cGMP) concentration 
inside the OS is high enough to maintain a fraction of cGMP-gated cation channel (CNG) in the 
open conformation. The influx of cations, Na+ and Ca2+, through the CNG channel keeps rod in a 
depolarized state (Figure 1.2). Upon photon capture by rhodopsin, 11-cis-retinal is 
photoisomerized to all-trans-retinal, resulting in a series of conformational changes in rhodopsin 
molecule that ultimately leads to an activated form of rhodopsin called Metarhodopsin II (R*), 
which facilitates the exchange of GDP for GTP on the α subunit of transducin. Tα-GTP activates 
cGMP phosphodiesterase (cGMP-PDE) by binding and relieving the inhibitory constraints 
imposed by PDEγ subunits on the catalytic PDEα and PDEβ subunits. Activated PDEαβ is a 
highly efficient enzyme working at diffusion limit and catalyzes the hydrolysis of cGMP to 
5’GMP (Burns and Arshavsky 2005). The drop in cGMP concentration leads to the closure of the 
CNG channels and membrane hyperpolarization. This drop in the rod membrane potential 
decreases the release of glutamate at photoreceptor synapse, which is sensed by retinal bipolar 
cells and parallel processed in retinal circuits before it is sent to the brain (Figure 1.3). Without 
phototransduction, a willing brain finds no input signal to decipher.   
 In order for rod to capture the next photon, all active molecules produced during the 
phototransduction cascade must be turned off (Figure 1.4). Several reactions take place 
simultaneously during the so-called recovery phase of phototransduction in order to reset the 
system. First, R* has to be deactivate to prevent its coupling to transducin. R* is phosphorylated 
by G-protein-coupled receptor 1 (GRK1) (Chen, Burns et al. 1999), followed by the binding of 
arrestin to the phosphorylated-receptor (Xu, Dodd et al. 1997; Burns, Mendez et al. 2006) 
(Figure 1.4A). This two-step reaction uncouples R* from transducin and allows for Schiff base 
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hydrolysis to dissociate the isomerized chromophore all-trans-retinal from rhodopsin. 
Regeneration of 11-cis-retinal is through an elaborated process named “the visual cycle” and 
involves the adjacent retinal pigment epithelium (Arshavsky 2002; Kusakabe, Takimoto et al. 
2009). Second, the G-protein transducin has to be turned off and this is achieved by the intrinsic 
GTPase activity that removes the gamma phosphate of bound GTP. The intrinsic rate of GTP 
hydrolysis is rather slow when assayed in vitro and to speed up the rate of transducin 
deactivation, a GAP complex accelerates the GTPase activity. This GAP complex is comprised 
of RGS9-anchoring protein (R9AP) (Hu and Wensel 2002; Hu, Zhang et al. 2003; Hu and 
Wensel 2004; Keresztes, Martemyanov et al. 2004), Regulator of G-protein Signaling 9 isoform 
1 (RGS9-1) (Cowan, Fariss et al. 1998; He, Cowan et al. 1998; Chen, Burns et al. 2000), and the 
long form of the fifth member of the Gβ family (Gβ5-L) (Watson, Aragay et al. 1996; Chen, 
Eversole-Cire et al. 2003; Krispel, Chen et al. 2003; Rao, Dallman et al. 2007) (Figure 1.4B). 
Upon GTP-hydrolysis, Tα-GDP loses its affinity for PDEγ. The free PDEγ re-associates with and 
inactivates PDEαβ. Third, the calcium and cGMP concentration are restored to the dark level 
through a Ca2+-feedback mechanism. To achieve this, the Ca2+ sensors, guanylyl-cyclase 
activating proteins (GCAP) (Mendez, Burns et al. 2001; Burns, Mendez et al. 2002; Howes, 
Pennesi et al. 2002; Mendez and Chen 2002; Pennesi, Howes et al. 2003), detect the drop in 
intracellular Ca2+ concentration and activate photoreceptor membrane bound guanylyl cyclase 
(GC) (Lowe, Dizhoor et al. 1995; Karan, Frederick et al. 2010). Guanylyl cyclase catalyzes the 
de novo synthesis of cGMP from GTP and restores cGMP level. As cGMP concentration 
increases, the CNG channel reopens to allow the influx of Ca2+ and Na+ ions (Figure 1.4C). The 
cation influx restores the so-called “dark current” to the photoreceptor and tonically increases 
glutamate release at synaptic terminal.  
The differences between cone and rod 
 Both rod and cone phototransduction use cGMP as the second messenger to transduce 
light, and a similar but distinct set of genes are used. There are many intrinsic differences 
between the two photoreceptor types and are responsible for their distinct contributions to vision. 
While rod phototransduction has been well characterized in the past 40 years (Fu and Yau 2007), 
it is a consensus now that understanding cone activation and deactivation constitutes the next 
frontier in phototransduction research (Kawamura and Tachibanaki 2008). Rod 
phototransduction is highly sensitive to light but lags behind in spatial resolution. Cone on the 
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other hand has high temporal resolution but it is much less sensitive to light. Rod is capable of 
responding to single photon (Rieke and Baylor 1998; Doan, Mendez et al. 2006), whereas cone 
requires approximately 100 times greater intensity of light to generate a photoresponse. 
Kinetically, rod photoresponses are slower and saturate faster, while in cones they are faster and 
do not saturate even at high intensities. Structurally, rod and cone photoreceptors have distinct 
outer segment morphology as their names suggest. The rod-shaped ROS has a diameter and 
length of 1.4 and 24 µm, respectively, whereas the cone-shaped COS has on average 1.2 and 13 
µm (Carter-Dawson and LaVail 1979). The disc membranes in rod are stacked lipid layers that 
are discontinuous and separated from the plasma membrane. In contrast, cone disk membranes 
are shorter, formed by membrane invagination and are continuous with the plasma membrane 
(Shichida and Matsuyama 2009). The smaller OS in cones may contribute to their faster response 
kinetics as the effective concentration of the phototransduction proteins is increased. At the same 
time, the open disc formation gives cone a larger surface area for chromophore dissociation and 
exchange during pigment regeneration. Another key difference between the two photoreceptor 
types is how they are coupled to their downstream circuitry at the outer plexiform layer (OPL) 
(Mustafi, Engel et al. 2009). While rod bipolar cells receive inputs from many rods, cone bipolar 
cell received information from much less cones. In extreme cases in primate retina, one cone 
bipolar cell is found coupled to only one cone photoreceptor. The rod circuitry is design to 
maximize sensitivity by having a high conversion factor. Conversely, the low convergence of the 
cone circuitry results in reduction in sensitivity but enhancement in acuity. 
 In addition to structural and network differences between rod and cone, almost all the 
players in the phototransduction cascade, such as visual pigments, transducin, GRKs, arrestin, 
CNG channel, and Na/K, Ca2+ exchanger are different for cone (Larhammar, Nordstrom et al. 
2009; Shichida and Matsuyama 2009). While rhodopsin is the light receptor for rod, different 
cone pigments with different action spectra are found in cones. In human three types of cones 
exist: short wavelength (S), medium wavelength (M), and long wavelength (L). The cone 
composition in other species varies and in mouse only two types of cones are present: S and M 
cones (Applebury, Antoch et al. 2000). The mouse S-cone opsin and M-cone opsin are 
maximally sensitive at wavelengths 360 and 508 nm, respectively. Another difference between 
rod and cone is their OS structure. The open disc structure of COS gives cone a larger surface 
area to allow for faster chromophore dissociation and exchange in regenerating the visual 
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pigments, which, in turn, may contribute to faster cone physiology (Mustafi, Engel et al. 2009). 
In addition to different opsin composition, rod and cone have different transducin subunits. Rod 
transducin is made up of Gαt1/Gβ1/Gγ1, whereas cone transducin is comprised of 
Gαt2/Gβ3/cone Gγ  (Lerea, Somers et al. 1986; Fung, Lieberman et al. 1992; Lee, Lieberman et 
al. 1992; Peng, Robishaw et al. 1992). Rod transducin (Gαt1/Gβ1/Gγ1) has been observed to 
undergo light-dependent translocation from OS to IS (Kerov, Chen et al. 2005; Chen, Wu et al. 
2007; Lobanova, Finkelstein et al. 2007). The translocation event is a light-adaptation 
mechanism for rod to protect itself under bright light condition. However, cone transducin does 
not normally undergo translocation except when illumination is so bright that bleaches all cone 
pigments (Lobanova, Herrmann et al. 2010). A recent study reveals that Gαt2 (GNAT2) also 
moves in a light-dependent manner when placed in rods (Chen, Woodruff et al. 2010). While the 
molecular mechanism in light-dependent protein translocation in rod remains unclear, a 
chaperone protein may be responsible in rod trafficking and absent in cone. Furthermore, 
replacing Gαt2 in Gαt1-/- (GNAT1-/-) rods causes reduced sensitivity, slower activation, but faster 
recovery kinetics. This study demonstrates that the rod and cone differences can be partially 
attributed to different transducin α subunits used by cone and rod and that the translocation 
phenomenon is not dependent on the Gα subunits but on the cells where they reside.  
In addition to opsin and transducin, the cGMP-gated channels in cones are also different 
from the ones in rods. The cGMP-gated channels belong to the cyclic-nucleotide gated (CNG) 
channel family and are tetrameric channels. Rod CNG channel is made up of 3 CNGA1 and 1 
CNGB1 subunits, whereas cone CNG channel is made up of 2 CNGA3 and 2 CNGB3 subunits 
(Weitz, Ficek et al. 2002; Zheng, Trudeau et al. 2002; Zhong, Molday et al. 2002; Peng, Rich et 
al. 2004). In heterologous system, CNGA1 and CNGA3 subunits can form functional homomeric 
channels, while CNGB1 and CNGB3 cannot. CNGB1 and CNGB3 require the CNGA subunits 
to form functional channel and contribute to variation in channel properties, such as conductance 
and drug sensitivity. It is obvious that the variation in the components of phototransduction 
machinery must contribute to the differences between rod and cone. However, the kinetic 
consequence on what makes a rod a rod or a cone a cone requires detailed characterizations. One 
way to further elucidate rod-cone differences is to swap phototransduction components between 
the two cell types, which is an active area of work currently ongoing in the lab.  
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Unlike rod, isolating mouse cone photoreceptors for biochemical and 
electrophysiological studies has been difficult due to its rarity (3% of the photoreceptors) and 
fragility. Meanwhile, wild-type cones in different species are being characterized in recent years 
to compare its kinetic properties to rods (Tachibanaki, Tsushima et al. 2001; Nikonov, 
Kholodenko et al. 2006). The cone phototransduction proteins provide for its faster kinetics, but 
with lower sensitivity. Each reaction in the cone phototransduction cascade has been carefully 
quantified and overall is less efficient than its corresponding reaction in rods. In carp (freshwater 
fish), four types of cones are present, red, green, blue and UV-sensitive, which makes up for 2% 
of its photoreceptor (Kawamura and Tachibanaki 2008). Of these cones, 60% are red cones 
containing red-sensitive pigments. Comparing the flash intensities required to illicit half-
maximal response, it was determined that the overall amplification of carp cone, from pigment 
activation to cGMP hydrolysis, is ~250 times less efficient than rod. The decrease in efficiency is 
the combined effect of decreased activation in cone transducin and cone PDE6. In rod, one 
activated pigment (R*) activates 54 transducin per second. On the other hand, cone transducin is 
estimated to be activated at a rate of ~2 molecules/s per activated cone pigment. This is a ~30 
fold difference in the activation between rod and cone transducin. To account for the overall 250-
fold difference in amplification, cone PDE is calculated to have 10-fold decrease in activation 
efficiency by cone transducin. All these factors contribute to the kinetic differences between rod 
and cone phototransduction.  
 While cone amplification is lower resulting in its decreased sensitivity, the fast recovery 
of cone response provides for its high acuity. The fast response in cone must imply that the 
reactions responsible for terminating the active species and regenerating the dark current are 
faster than rod. Carp cones express GRK7 instead of GRK1, the GRK in rods, in the deactivation 
of cone opsin (Tachibanaki, Tsushima et al. 2001; Shimauchi-Matsukawa, Aman et al. 2005; 
Tachibanaki, Arinobu et al. 2005; Wada, Sugiyama et al. 2006). After light stimulation, cone 
opsin is phosphorylated at 5 phosphates per R*/s, which is 50 times higher than the reaction in 
rods at 0.09 phosphates per R*/s. Interestingly, the opsin phosphorylation occurs in the recovery 
time course in cone, which suggests pigment deactivation may determine the speed of cone 
recovery.  
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In addition to faster opsin deactivation, transducin turn-off and cGMP regeneration must 
also be faster in cone to re-establish cGMP level and reopen the CNG channel. Studies in the 
eastern chipmunk, a cone dominant retina, estimated that cone expresses 10-fold higher level of 
RGS9-1 than rod, which will accelerate cone transducin deactivation (Cowan, Fariss et al. 1998). 
Also, rod and cone in different species express different sets of GCAP and GC proteins, which 
may contribute to differences in cGMP synthesis between rods and cones. The role of GCAPs 
and GCs in the recovery of phototransduction will be further discussed in the next section. 
Structurally and biochemically, cones have distinct characteristics that give them the unique 
ability to provide for fast and high temporally resolved vision.  
Mouse Cone Photoreceptors and Nrl-/- retina 
To detect light across different wavelength for color vision, cone opsin expression 
dictates the sensitivity in different cone photoreceptors. S opsin (Opn1sw) is expressed in the 
short-wavelength sensitive (SWS) cones and is maximally stimulated by light between 415-430 
nm. M opsin (Opn1mw) is expressed in the middle-wavelength sensitive (MWS) cones and is 
maximally stimulated by light between 530-537 nm (Marc and Sperling 1977; Mustafi, Engel et 
al. 2009). Mouse cone system does not contain the L cone, unlike primates that contain all three 
types of cones to mediate trichromatic vision. As a nocturnal species, mouse possesses a rod-
dominated retina and L cone may not be needed and hence eliminated during evolution (Jacobs 
2009; Mustafi, Engel et al. 2009). The cone distribution across different species also varies, 
dependent on the species’ nocturnal and diurnal cycle. In human cone system, cone density is 
concentrated at the fovea to provide for high visual acuity. In contrast, mouse cones are 
distributed evenly across the retina, with a density of 1.2 x 104 cells mm-2, mimicking the 
peripheral region of primate retinas. Furthermore, mouse cone photoreceptors have a unique 
spatial patterning between S and M cones (Applebury, Antoch et al. 2000). S cones are highly 
localized in the inferior (ventral) region, while M cones are concentrated in the superior (dorsal) 
region of the retina. Although S and M are the two cone types in mouse, their cone opsin 
expressions are not mutually exclusive (Lyubarsky, Falsini et al. 1999; Akimoto, Filippova et al. 
2004). It has been shown that β-galactosidase (lacZ reporter) driven by the human M cone 
promoter is expressed in both cone types (Wang, Macke et al. 1992). Message quantification of 
rod and cone opsin indicates a ratio of 1000:30:10 for rhodopsin:S-opsin:M-opsin mRNAs. The 
higher S opsin mRNA level over M opsin reflects that there are more S opsin than M opsin per 
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cone and/or more S cones than M cones. Moreover, S and M cone opsins are co-expressed in the 
cones in the inferior hemisphere, but less in the superior hemisphere. In the superior hemisphere, 
M cone opsin is expressed without any S opsin. These results demonstrate that cone distributions 
are graded and opsin expression is dependent on the promoter strength in each cone 
photoreceptor. In fact, recent study shows that M-opsin expression increases when S-cone is 
down-regulated in mouse, confirming that the translational machinery in cones regulates the 
expression of S and M cone opsin (Daniele, Insinna et al. 2011). Competition on the same 
translational regulatory elements can determine the level of S and M opsin expression in cone 
photoreceptor. Based on primary structure, mouse S opsin is ~85% identical to other mammalian 
SWS pigments (Yokoyama and Radlwimmer 1998; Yokoyama, Radlwimmer et al. 1998). It 
forms an Schiff base linkage with 11-cis-retinal at Lys291 and has a λmax of 360 nm. The mouse 
M cone opsin has a λmax of 508 nm and is similar to the red and green cone (L/M) opsin family. 
Mouse cone opsins have different λmax from primate opsins, which may be attributed to structural 
variations. The variations in cone distribution and its opsin expression and characteristics can 
contribute to the sensitivities, spatial resolution and to how different species perceive and 
interpret their environment. 
It has been suggested mouse cone is the ancestral photoreceptor in which rod derives 
from (Jacobs 2009; Mustafi, Engel et al. 2009). Cone makes up 3% of the photoreceptors in the 
mouse retina, where their nuclei reside in the outer half of the ONL and sit close to the outer 
limiting membrane (OLM) (Carter-Dawson and LaVail 1979). Under light microscopy, COS 
diameter is thicker and more transparent compared to ROS. COS may have evolved as the disc 
membrane become separated from the plasma membrane to become the OS found in rod 
photoreceptors. This step in photoreceptor evolution is required as animals adapt to darker 
environments. As mentioned in previous sections, rod has similar but a distinct set of 
phototransduction proteins that vary from cone. Therefore, there must be a transcription switch 
that determines the differentiation between rod and cone during development. One such 
molecules is neural retina leucine zipper (Nrl), a transcription factor that has been found to 
upregulate protein expression of rod-specific genes and indirectly suppresses cone-specific genes 
through its interaction with Nr2e3 (Mears, Kondo et al. 2001). NRL contains a basic leucine 
zipper motif, which recognizes and binds Nrl response element (NRE). Along with other 
transcription factors such as Crx, Nrl associates with the NRE on rhodopsin promoter to 
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upregulate rhodopsin expression. The role of Nrl in photoreceptor development has been verified 
in the knockout mouse, which has a ‘rodless’ or cone-like retina (Daniele, Lillo et al. 2005; 
Nikonov, Daniele et al. 2005). The photoreceptors in Nrl-/- have similar sensitivity and nuclear 
structures to wild-type cones. In particular, the nuclear structures show a pattern of 
heterochromatin, similar to the ones in wild-type cones. mRNA and protein analysis demonstrate 
that Nrl-/- photoreceptors have cone-specific protein expression, such as cone transducin, S opsin, 
and cone arrestin, whereas rod-specific proteins (rhodopsin and rod transducin) are not 
detectable. While Nrl-/- photoreceptors share many hallmarks of a typical cone, Nrl-/- ‘cones’ 
appear to have disorganized disk morphology with shorter outer segments. Also, these ‘cones’ 
undergo a slow degeneration, evident by an age-dependent decrease in their ERG responses. Nrl-
/- photoreceptors seem to adopt a S-cone phenotype as its ERG amplitude is greater than WT 
response when stimulated with a 400 nm light, which is absorbed by S opsin. The increase in 
ERG responses corresponds with a higher S opsin expression in Nrl-/- retina. In contrast, M cone 
opsin expression does not change comparing WT and Nrl-/- photoreceptors, which is reflected in 
similar ERG responses when stimulated with a 530 nm stimulus. The enhanced S cone 
phenotype in Nrl-/- retina suggests that the default fate of photoreceptor progenitors may be S 
cone photoreceptors. The “cone-like” photoreceptors in Nrl-/- retina have been useful in the study 
of the biochemical and physiological properties of cone photoreceptor. 
 Physiologically, cone properties in WT and genetically modified mouse have been 
investigated using Electroretinogram (ERG), which does not give single-cell resolution (Ekesten, 
Gouras et al. 1998; Lyubarsky, Chen et al. 2000). On a single cell level, rod photoreceptors have 
been well characterized through suction pipette recording on the outer segments (Baylor, Lamb 
et al. 1979). However, the characterization in cone kinetic has been difficult due to its rarity and 
frailty of COS in the mouse retina. Instead of using the outer segments, the inner segments have 
been exploited to record cone photoresponses in recent studies (Nikonov, Daniele et al. 2005; 
Nikonov, Kholodenko et al. 2006). The inner segment (IS) contains K+ channels to carry the 
outward membrane current, which is transduced from the OS. After light stimulation, the closure 
of CNG channels at the OS reduces the inward membrane current and hyperpolarizes the cell. 
The hyperpolarization then continues to the IS, which eliminates the outward current through the 
K+ channel. This change in outward current is captured through suction pipette recording. In 
addition, the recordings are carried out in the presence of a 500 nm background light to suppress 
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the rod response. To discern the type of cone under recording condition, cone responses from 
361 and 501 nm flashes are compared. As most mouse cones express both S and M cone opsins, 
the one with the higher expression would be maximally stimulated by the corresponding 
wavelength of light. The responses are derived from S cone if the cone is maximally stimulated 
at 361 nm, or M cone if maximally stimulated at 501 nm. The location of the S and M cones also 
corresponds with their light sensitivity, with M cone in the superior region and S cone in the 
inferior region.  IS recordings on sliced wild-type retina have demonstrated that S and M cones 
have similar flash kinetics and response properties, despite their differences in cone opsin 
expression (Nikonov, Kholodenko et al. 2006). Wild-type cones respond with a 0.2% decrease in 
membrane current per photoisomerization. The sensitivity (the amount of light needed to obtain 
half-maximal response) of mouse cones is 2x105 photon µm-2s-1, which is more than 40 fold 
lower than a mouse rod at 350 photon µm-2s-1. S and M cones have time-to-peak (tpeak) values of 
73 and 63 ms and a dominant recovery time constants (τD) of 73 and 68 ms, which are 
considerably faster than rod responses with tpeak of 205 ms and τD of 235 ms. Similar parameters 
are also obtained in GNAT1-/- animals, except with a slower τD of ~110 ms. The cone recording 
in wild-type mouse is performed in the presence of background light, while GNAT1-/- cone is 
recorded without background light since deleting transducin removes rod photoresponses 
(Calvert, Krasnoperova et al. 2000). Light adaptation has been demonstrated to accelerate the 
recovery of rod photoreceptors. Similarly, WT cone recovery becomes accelerated under light 
adaptation, hence the lower τD in wild-type cones compared to GNAT1-/- cones. Comparing rod 
and cone, the cone recovery of 110 ms in GNAT1-/- animal is two times faster than WT rods 
around 235 ms. Using the cone IS, it is now possible to study cone physiologically in WT and 
genetically manipulated mice and to understand it unique role in the visual system. 
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CHAPTER 2 
Deactivation of cone transducin rate-limits the recovery of cone photoreceptors 
Introduction 
 The recovery of photoreceptors after light stimulation requires (1) receptor deactivation 
by GRK1 phosphorylation and arrestin binding (Chen, Burns et al. 1999; Lyubarsky, Chen et al. 
2000), (2) GTP hydrolysis by transducin, which is accelerated by a GAP complex containing 
RGS9-1/Gβ5-L/R9AP (Chen, Burns et al. 2000; Krispel, Chen et al. 2003; Nishiguchi, Sandberg 
et al. 2004; Krispel, Chen et al. 2006), and (3) restoration of cGMP level to re-open CNG 
channel to resume the circulating “dark-current” (Burns, Mendez et al. 2002). Disruption in any 
of the reactions during recovery results in prolonged activation. Mutations in genes involved in 
some of these recovery steps have been identified in human and in animals, which lead to 
various forms of visual defects including bradyopsia, congenital stationary night blindness, 
Leber’s congenital amarousis, cone/rod dystrophy (Cideciyan, Zhao et al. 1998; Nishiguchi, 
Sandberg et al. 2004; Cideciyan 2010; Karan, Frederick et al. 2010; Michaelides, Li et al. 2010). 
Studying genetic modified mice have provided insights on the reactions important for 
photoreceptor recovery and mechanisms involved in the pathology of some of these diseases. 
Mouse without GRK1 (GRK1-/-) or arrestin (Arr1-/-, or Arr4-/-) has a severe delayed rod recovery, 
confirming that GRK1 and arrestin are the main players responsible for deactivating R* in rod 
(Xu, Dodd et al. 1997; Chen, Burns et al. 1999; Lyubarsky, Chen et al. 2000). Without GRK1 or 
arrestin, R* remains active for a very long period of time and because it takes just a few hundred 
R* to saturate rod’s photoresponse, rod sensitivity in affected individuals does not return until all 
R* is deactivated by spontaneous decay.  This takes minutes instead of milliseconds. Recessive 
mutations in GRK1 and arrestin have been identified in patients of Oguchi Disease, a type of 
congenital stationary night blindness (Fuchs, Nakazawa et al. 1995; Cideciyan, Zhao et al. 1998; 
Hayashi, Gekka et al. 2007; Oishi, Akimoto et al. 2007). These patients have difficulties with 
night vision, which correlates with defective R* deactivation. We will set aside Oguchi Disease 
and its relation with GRK1 for now, and will discuss it further in Chapter 3.  
 Similar to defective rhodopsin phosphorylation or arrestin binding that prolongs 
rhodopsin lifetime that delays rod recovery, additional loss of function manipulations in different 
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recovery steps may also prolong phototransduction. As the RGS9-1/Gβ5-L/R9AP GAP complex 
facilitates transducin turn-off, defects in any components of this GAP complex may delay rod 
recovery. In photoreceptors of RGS9-/-, Gβ5-/- or R9AP-/- mouse, they posses very similar delay 
in rod recovery as transducin deactivation is not assisted and depends on a slower endogenous 
rate of GTP hydrolysis by transducin α subunit (Chen, Burns et al. 2000; Krispel, Chen et al. 
2003; Keresztes, Martemyanov et al. 2004). It is now known that the level of R9AP determines 
the overall levels of Gβ5-L and RGS9-1 and that some components like RGS9-1 and Gβ5-L are 
obligate partners to each other because in the absence of one, the other becomes unstable and is 
subject to proteolysis (Chen, Eversole-Cire et al. 2003; Keresztes, Martemyanov et al. 2004).  In 
RGS9-/-, Gβ5-/- and R9AP-/- photoreceptors, the GAP complex is similarly abolished to result in 
the reduction of transducin GTPase activity. In fact, the recovery time constants, τrec and τD, are 
slowed from 180 and 270 ms in control rods to 2600 and 9000 ms in rods lacking the GAP 
complex. Such an increase in recovery time constant in the absence of the GAP complex may 
reflect the basal GTPase activity of transducin in rod differs under dim and bright flash 
conditions, where τrec and τD are determined, respectively.  Alternatively, this may suggest that 
under dim light condition where much less activated transducin is present in rod, some other 
protein may facilitate transducin GTP hydrolysis (Chen, Burns et al. 2000).   
 Another indispensable reaction for rod recovery is the restoration of cGMP level in order 
to reestablish the “dark current” (Fu and Yau 2007). This is accomplished by light-dependent 
regulation of guanylyl cyclase activating proteins (GCAPs), members of the Ca2+-binding protein 
family, on guanylyl cyclases (GCs). GCAPs are molecular switches on GC activity during dark 
to light transition. Under high Ca2+ level in the dark, Ca2+-bound GCAPs inhibit GCs and the rate 
of cGMP synthesis is low. After light exposure, the drop in cGMP level after PDE6 activation 
leads to the closure of the CNG channels and the decrease in Ca2+ influx. In the duration that the 
channels are closed, the Na+/Ca2+/K+-exchanger (NCKX) continues to extrude intracellular Ca2+ 
out of the OS at the ratio of 4Na+/1Ca2+/1K+. The combine effect of channel closure and Ca2+ 
efflux after light illumination results in the drop in Ca2+ concentration and membrane 
hyperpolarization (Yau and Nakatani 1984; Luo, Xue et al. 2008). As photoactivation drives 
Ca2+ down to the nanomolar (~30-50 nM) range (Fain, Matthews et al. 2001), unbound GCAP 
then stimulates GCs to increase the rate of cGMP synthesis, restoring cGMP level back to the 
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dark state to reopen the CNG channel and allows cation influx and photoreceptor depolarization. 
There are two GCAPs (Cuenca, Lopez et al. 1998; Howes, Bronson et al. 1998) and two GCs 
(Liu, Seno et al. 1994; Cooper, Liu et al. 1995; Lowe, Dizhoor et al. 1995) in mouse 
photoreceptors. GC1 and GCAP1 are present in rod and cone, whereas GC2 and GCAP2 are 
only present in rod. GC1 is activated by both GCAP1 and GCAP2, whereas GC2 is activated by 
GCAP2. The GCAP1 and GCAP2 proteins are ablated in mouse simultaneous as their genes are 
in a tail-to-tail arrangement. In animals lacking both GCAPs (GCAP-/-), rod recovery is delayed, 
since cGMP synthesis cannot be restored in a timely manner after Ca2+ level decreases (Mendez, 
Burns et al. 2001; Howes, Pennesi et al. 2002; Pennesi, Howes et al. 2003). Consistent with lack 
of Ca2+-feedback to restore cGMP concentration, the GCAP-/- rods have larger amplitudes and its 
SPR amplitude is five times higher than WT. Furthermore, the loss of GCAP abolishes the rod’s 
sensitivity to the large range of light stimulus. Recovery delay is rescued by restoring GCAP1 
expression in rod and cone (Howes, Pennesi et al. 2002). On the other hand, restoring GCAP2 
expression GCAP-/- restored the recovery kinetics at saturating light flashes, but not at sub-
saturating flashes (Mendez, Burns et al. 2001). These evidences suggest that GCAP1 has a more 
dominant role than GCAP2 in rod photoreceptors. GCAP2 may be less sensitive to Ca2+ changes 
in rods, hence its inability to properly recover rod at lower flash intensities. Overall, GCAPs 
regulation on GCs is important in setting the rod’s light sensitivity and for the Ca2+-feedback on 
regenerating the cGMP level and the “dark current”. 
 It is evident the three reactions described above are required for photoreceptor recovery 
and any deficiency in these steps results in the loss of the photoreceptor’s sensitivity and 
compromises spatiotemporal resolution of phototransduction. However, there was a big debate in 
the timing and interplay of these recovery reactions before 2006, in which under normal 
condition which of these reactions rate-limits the overall rate of recovery. It is conceivable that 
the slowest reaction will determine how fast photoreceptor can recover. Genetic ablation of 
genes responsible for any of these reactions may artificially slow down the recovery; therefore it 
does not reveal whether a particular reaction is rate-limiting under normal condition. Because the 
Loss of function (LOF) approach is not suitable to find the rate-limiting step, a gain of function 
(GOF) approach is devised to tackle the question by transgenically increasing the concentration 
of the enzyme responsible for the slowest step to alter the overall recovery of phototransduction. 
It has been found by overexpressing R9AP in rod that the concentration of RGS9-1 and Gβ5-L 
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can be elevated (Krispel, Chen et al. 2006). By increasing the level of GAP complex, the GTP-
hydrolysis of transducin is accelerated and rod recovery is sped up. The τrec and τD are sped up 
from 190 and 246 ms in control rods, to 74 and 80 ms, respectively. Furthermore, the degree of 
recovery acceleration is a function of GAP overexpression. In a more recent study a recovery 
time constant of 54 ms was recorded with a 6-fold overexpression of GAP (Chen, Woodruff et 
al. 2010). A decrease in recovery time constant (faster recovery) demonstrates that GTP-
hydrolysis of transducin is the slowest step in the recovery phase of rod phototransduction. At 
the time I joined the lab, it became clear to me that one of the obvious standing question was 
whether cone photoreceptor shares the same rate-limiting step for its recovery. This is an 
important question to answer because it has been shown that cone possesses a higher RGS9-1 
level than rods in many species examined including human, bovine, mouse and chipmunk. In the 
chipmunk case, the level of overexpression in cone reaches ten-fold (Cowan, Fariss et al. 1998).  
Can such a high amount of GAP complex in cone change the identity of the rate-limiting step of 
cone recovery?  If the turn-off of cone transducin does not rate-limit cone recovery, what is the 
real rate-limiting step? 
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Methods 
Transgenic constructs and mouse husbandry 
In this study, a similar GOF approach in Krispel et al is used to overexpress the GTPase-
accelerating protein (GAP) complex in mouse cone photoreceptors. Two transgenic constructs, 
MCV9 and MCV10, are generated to drive R9AP overexpression in S and M cones, respectively. 
MCV9 construct consists of the 520 bp human blue opsin promoter (Akimoto, Filippova et al. 
2004), flanked by R9AP and terminated with a protamine polyadenylation (pA) signal. The blue 
opsin promoter is subcloned into pBluescript (Stratagene, Santa Clara, CA) using KpnI and 
XhoI, along with the pA signal using BamHI and NotI, to generate the pBOP1.1 plasmid. R9AP 
is placed downstream to the promoter in pBOP1.1 using XhoI and BamHI. The transgenic 
construct was linearized with KpnI and NotI and submitted to the VCU Mouse Core Facility for 
nuclear injection. MCV10 was generated in a similar manner deriving from pGOP1.1 plasmid, 
which contained the 5 kbp green opsin promoter (Akimoto, Filippova et al. 2004). The presence 
of MCV9 and MCV10 transgenes are confirmed with PCR on digested mouse tail DNA using 
the primer sets described in Table 2.1. The amplification conditions for PCR are: 94°C for 5 
minutes, then 35 cycles of 94°C for 1 minute, 64°C for 1 minute, and 72°C for 1 minutes and 
followed with a final extension of 72°C for 5 minutes. For MCV10, six founders are generated 
with line 1, 5, and 6 overexpressing RGS9-1. Line 6 is carried forth for characterization. R9AP+/-
, MCV9 and MCV10 are mated into GNAT1-/- (designated as ‘T’) (Calvert, Krasnoperova et al. 
2000) to remove the rod interference and facilitate single-cell recordings. At the same time, 
MCV9 and MCV10 were crossed into R9AP-/- background to allow western quantification of the 
RGS9-1 overexpression in cones. Genotyping conditions for the animals used in this study are 
listed in Table 2.1. 
The opsin promoters are utilized to drive cone-specific expression of human GRK7 
(hGRK7). The hGRK7 cDNA is inserted into pBOP1.1 and pGOP1.1 between the promoter and 
the pA signal with XhoI and BamHI to generate the pBOPGRK7 (MCV7) and pGOPGRK7 
(MCV8) constructs. The constructs were linearized with KpnI and NotI to remove the 
pBluescript backbone and submitted to the VCU Mouse Core facility for nuclear injection. The 
presence of the MCV7 and MCV8 transgenes was confirmed with PCR on digested tail DNA 
using the following primer sets described in Table 2.1. The amplification conditions for detecting 
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the transgenes were: 94°C for 5 minutes, then 35 cycles of 94°C for 1 minute, 64°C for 1 minute, 
and 72°C for 1 minutes and followed with a final extension of 72°C for 5 minutes. For MCV8, 8 
founder lines were identified and line 2 and 8 had GRK7 expression with IHC. Based on the 
fluorescent intensity, line 2 expressed higher level of GRK7 than line 8 and hence was carried 
forth for characterization. For characterization, MCV7 and MCV8 animals were mated in GRK1-
/- (Chen, Burns et al. 1999) to remove the endogenous GRK1. 
Immunohistochemistry 
A small burn mark was placed on the superior side of the mouse cornea before the eyes 
were dissected in 1X PBS (Phosphate-buffer saline, pH 7.4). A small incision was made on the 
cornea near the ora serrata to allow fluid permeation. The eyeball was fixed overnight in 4% 
paraformaldehyde (PFA) in 1X PBS at 4°C. After fixation, the cornea and the lens were carefully 
removed and the eyecup was cryo-protected in 30% sucrose in 1X PBS at 4°C. After the eyecup 
settled in the sucrose solution, it was embedded and frozen in TBS (Triangle Biomedical 
Sciences, Durham, NC, USA) at -80°C. Frozen eyecup blocks were sectioned at 24 µm and 
placed on microscope slides. For immunostaining, sections were washed three times with 1X 
PBS at five minutes each. Washed sections were blocked with 10% goat serum in PBT (0.3% 
Triton X-100 in 1X PBS) for 1 hour at room temperature (RT). Blocking solution was removed 
before adding the primary antibody. Primary antibodies, CT318 (1:200) and FITC-conjugated 
PNA (1:500), were diluted with 10% goat serum in PBT, applied over the section, and incubated 
overnight at RT. After incubation, sections were washed three times with PBT at five minutes 
each. After washing, Alexa-568 conjugated goat-anti-rabbit secondary antibody was diluted at 
1:1000 with 10% goat serum in PBT, added to the sections and incubated for two hours at RT. 
After incubation, sections were washed three times with PBT at ten minutes each. After washing, 
sections were protected with ProLong Gold antifade reagent (Invitrogen, Carlsbad, CA), 
mounted with cover slips, and sealed with nail polish. Confocal images were taken with Zeiss 
META LSM 510 confocal microscope (Carl Zeiss Microimaging, Thornwood, NY, USA) in the 
VCU Microscopy Core Facility (Department of Anatomy and Neurobiology, Virginia 
Commonwealth University). Images were viewed on LSM Image Browser program (Carl Zeiss 
Imaging, Thornwood, NY, USA) without any post-hoc adjustments.  
Immunostaining of flat-mount retina (Perform by Mr. Yen-Lin Chen) 
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Mouse eyeball was dissected in the similar fashion as for IHC. After the removal of the 
cornea and the lens, sharp, fine scalpel was used to cut the retina into four quadrants. The 
superior and inferior quadrants were retained and the other two was discarded. The retina from 
the quadrants was carefully pealed away from RPE using a fine brush and flattened onto 
nitrocellulose filter paper with the photoreceptor side facing up. The flattened retinas were fixed 
in 4% PFA in 1X PBS overnight at 4°C. After fixation, staining was performed in 0.6 mL 
microfuge tubes. Retina was washed three times with 1X PBS at five minutes each. Similar 
procedure was carried out as for IHC with a few modifications. The primary antibodies 
incubation was performed with gentle rocking at 4°C for two days to allow antibody penetration. 
After mounting and sealing, images were taken immediately using the Zeiss META LSM 510 
confocal microscope at 63X magnification. 
Immunoquantification 
ImageJ software (NIH, USA) was used to trace the RGS9-1 signals in rods and cones to 
determine their average fluorescent intensities in the retinal cross section and flat-mount retinas 
on single optical slices. The cone RGS9-1 intensities were selected based on the surrounding 
PNA signals. To quantify the relative RGS9-1 expression in T (GNAT1-/-), 9T (MCV9 in 
GNAT1-/-), 10T (MCV10 in GNAT1-/-), and 910T (MCV9 and MCV10 in GNAT1-/-), the cone 
signal was normalized to rod level in both the superior and inferior hemisphere of the retina. 
Then to determine the level of RGS9-1 overexpression in the transgenic lines, the relative levels 
were normalized to the cone level in T. Statistics were performed in SigmaPlot and One-way 
Anova was used to compare the level of overexpression across different genotypes. Significance 
is established with p ≤ 0.05. 
Western Blot 
Mice were euthanized with CO2, followed with cervical dislocation. Eyeballs were 
removed with forceps and placed in 1X PBS for dissection. The cornea and lens were removed 
before separating the retina from the retinal pigmented epithelium (RPE). For one retina, it is 
homogenized in 75 µL 1X PBS and solubilized in 75 µL LSB Buffer, followed with incubation 
at 95°C for 10 minutes. Retinal proteins were resolved on a 12% Tris-HCl polyacrylamide gel 
and electrophoresed in 1X SDS-PAGE buffer at 150V for 100 minutes. Following SDS-PAGE, 
the proteins were transferred onto nitrocellulose membrane in 1X transfer buffer at 250 mA for 
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120 minutes. The membrane was stained with 0.1% Ponseau S in 5% glacial acetic acid to ensure 
the completion of protein transfer. Ponseau S was destained with distilled water and afterwards, 
the membrane was blocked in blocking buffer (10% milk in 1X TBST) for 1 hour at room 
temperature (RT). Primary antibodies (CT318, 1:6k, GAPDH, 1:50k) were diluted in blocking 
buffer and incubated with the membrane for 2 hours at RT. After primary antibody incubation, 
the membrane was washed four times in 1X TBST at 5 minutes each. HRP-conjugated goat-anti-
rabbit secondary antibody was diluted (1:30k) in blocking buffer and incubated with the 
membrane for 1 hour at RT. Following secondary antibody, the membrane was washed six times 
in 1X TBST at 10 minutes each before developing it using the SuperSignal West Dura 
Chemiluminescent Substrate (Thermo Scientific, Rockford, IL). Blot image was captured on film 
and on the Kodak Image Station 440 CF. 
Light stimuli (Provided by Dr. Lihui Cao) 
The light source was a 75-W Xenon arc lamp, modulated by a heat filter and arrays of 
calibrated neutral-density and 10-nm-band-pass interference filters. The beam was controlled by 
an electronic shutter and delivered to the microscope via a fiber-optic light guide. It was passed 
through an iris to control the spot size, with a circle area of 400 µm in diameter, and focused with 
a 40X objective. Flashes were delivered 10 ms in duration. The light intensity was periodically 
calibrated with a radiometer.  
Retinal slice recording (Provided by Dr. Lihui Cao) 
Mice at 30 to 60 days of age were reared in cyclic light, and dark-adapted overnight prior 
to an experiment. Mice were anesthetized by Avertin, and eyes enucleated, hemisected under 
infrared illumination. The retina was then attached to a nitrocellulose filter paper (Millipore, pore 
size 0.22 um), the pigment epithelium side down. The pigment epithelium was then peeled off 
with another filter paper quickly, now with the photoreceptor side up. The isolated retina on the 
filter paper was transferred to a chamber and fixed to its bottom with silicon grease. The 
chamber was filled with the standard solution. Most of the experiment performed under the 
Locke’s solution: 112.5 mM NaCl, 3.6 mM KCl, 2.4 mM MgCl2, 1.2 mM CaCl2, 10 mM 
HEPES, 0.02 mM EGTA, 20 mM NaHCO3, 3 mM Na2-succinate, 0.5 mM Na-glutamate, 10 mM 
glucose). The chamber was placed on the stage of a handmade mechanical slicer, and cut 
vertically in 150-200 µm thickness together with the filter paper. Several slices were then 
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transferred to the neighboring recording chamber and rollover with both ends fixed with silicon 
grease. A slice hold-down (a platinum-iridium frame strung) was sometimes used to prevent the 
retinal slice from floating.  
Experiments were carried out under precisely controlled temperature, which is 35.5-
36.5°C, monitored by a thermistor placed closely to the recording cell in the chamber. The bath 
solution was temperature-controlled before perfusion and heated up again when running close to 
the chamber, running at 100ml/hr. Using silanized suction pipettes with openings around 3.5-4.5 
µm, several cell bodies and the conjoined inner segment were sucked in. This protocol was first 
developed by Dr. Nikonov and used with some modifications (Nikonov, Daniele et al. 2005). 
Membrane current was measured with a current-to-voltage amplifier (Axon 200B; Axon 
instruments). All signals were low-pass filtered at 20 Hz (8-pole Bessel) and sampled at 10 kHz. 
The inner segment of the cone circulating current is an outward current, carried primary by K+ 
channels. Here all the data are presented in the conventional manner as positive-going.    
Brief flashes (10ms) of 380 nm light were delivered at 2.6s intervals. The effective 
collecting area, Ac, of an outer segment for incident light approximately perpendicular to the 
longitudinal axis of the outer segment is given by Ac=2.303Qαfπd2l /4, where Q is the quantum 
efficiency of the isomerization, α is the transverse specific optical density of the outer segment, 
and f is a factor that depends on the polarization of the incident light, d and l are the diameter and 
length of the outer segment, respectively. Here we adopted the previous measurements published 
by Nikonov (Nikonov et al, 2006), in which Ac of transducin knockout (GNAT1-/-) mouse is 0.2 
µm2, and Nrl-/- mouse is 0.11 µm2.  
Determination of Pepperberg time constant (Provided by Dr. Lihui Cao) 
 Assuming that light-activated PDE activity decays exponentially and the guanylyl cyclase 
activity is maximal and equal for the duration of the saturated response, the slope of the 
saturation time as a function of the natural log of the flash strength provides a estimate of the 
time constant for the decay of PDE activity, the slower component of the rhodopsin or transducin 
shutoff (Pepperberg, Cornwall et al. 1992). Saturation time was defined as the period over which 
the flash suppressed 40% of the dark current. 
29
	  
Results 
Relative level of RGS9-1 in mouse rod and cone photoreceptors 
 It was reported in cone-dominant chipmunk retinas that RGS9-1 level is ~10 times higher 
in cone than in rod (Cowan, Fariss et al. 1998). The overexpression was calculated based on the 
ratio of RGS9-1 protein expression normalized to opsin concentration in the cone-dominant 
chipmunk retina versus rod-dominant mouse and bovine retina. However, the overexpression 
may have been overestimated since 25% of the photoreceptors in chipmunk are rods. The RGS9-
1 level observed in chipmunk retina is, then, partially derived from rods and can lead to an 
overestimation of the relative RGS9-1 expression. To date, while numerous 
immunohistochemical examination of RGS9 expression in retinas of multiple species were 
reported, it has not been systematically determined how much more RGS9-1 mouse cone may 
have over rod. The quantification of cone RGS9-1 level has been challenging because in rod-
dominated retina such as mouse and bovine, cone cells make up a small fraction of total retinal 
photoreceptors. In the case of mouse, the number is ~3%. We sought to determine relative level 
of RGS9 in mouse cone and rod by performing quantitative IHC on mouse retinal sections using 
an anti-RGS9-1 antibody and a cone marker, peanut agglutinin (PNA). Qualitatively, it is very 
easy to see that RGS9-1 expression is indeed higher in cone (Figure 2.2A and 2.3A, ‘T’). To 
quantify the RGS9-1 level in cone, we compared and quantified the immunofluorescent 
intensities between rod and cones on both flat-mount retina and retinal sections. On a single 
optical slice of 0.39 µm, the rod and cone intensities (~4-8 cells) were outlined with the ‘draw’ 
option in ImageJ and the average intensities were calculated. Using this approach, we determined 
that RGS9-1 level in cones is approximately 1.6-fold over rods (Figure 2.2B, 2.3B, ‘T’). Our 
quantification of cone RGS9-1 level is considerably lower than the reported value in chipmunk 
(Cowan, Fariss et al. 1998), in which it was estimated to be 10-fold higher in cone than rod. This 
difference in RGS9-1 level in cones can conceivably be attributed to species difference between 
chipmunk and mouse. However, it is also possible that our immunofluorescence quantification 
may underestimate the level of cone RGS9-1 expression due to signal saturation in cone. The 
linear range of the IHC staining with CT318 (anti-RGS9-1 antibody) was not established in the 
immunoquantification of RGS9-1. If the staining is above the linear range, the 1.6-fold 
overexpression of cone RGS9-1 over rod is then an underestimation of the relative RGS9-1 level.  
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RGS9-1 overexpression in MCV9 and MCV10 transgenic lines 
 In mouse rod, the concentration of the GAP complex is determined by R9AP level, it is 
not known whether this is also true in cone. Assuming that R9AP expression level determines the 
overall GAP level in cones, we placed R9AP cDNA downstream of the blue and green opsin 
promoters (Figure 2.1C) and sought to overexpress GAP complexes specifically in cones. This 
resulted in the production of MCV9 and MCV10 transgenic lines overexpressing RGS9-1 in the 
S and M cones, respectively. Six MCV10 founders were generated that contained the transgene 
and among which lines 1, 5, and 6 were found to have a higher intensity of RGS9-1 staining in 
their cones. Line 6 was carried forth for further characterization because the homogeneity of 
RGS9-1 overexpression across retina.  To enable electrophysiological recordings, MCV9 and 
MCV10 animals were both crossed into GNAT1-/- (T) background to generate T, 9T, 10T and 
910T.  Putting them in the T background removes rod signals and facilitates cone recordings by 
removing the need to use background light to suppress rods, which may inadvertently cause light 
adaptation and/or rod/cone cross talk through electrical synapse involving GAP junctions.  
Eliminating the caveat concerning light adaptation is also important because one of the well-
established effects of light adaptation is accelerated recovery (Ekesten, Gouras et al. 1998). In 
the mouse retina, S-cone is distributed in higher density in the inferior hemisphere, while M-cone 
is distributed more in the superior hemisphere. As the blue opsin promoter drives S-cone specific 
expression, the cone RGS9-1 overexpression in the MCV9 was found predominantly in the 
inferior hemisphere. However, the cone RGS9-1 overexpression driven by the green opsin 
promoter in MCV10 was found in both superior and inferior hemispheres (Figure 2.2A). The 
homogenous cone overexpression of RGS9-1 in MCV10 may be due to the integration site of the 
MCV10 transgene, or the use of a larger promoter (5 kb vs. 550 bp), or both. It is also possible 
that the cones in the inferior region do contain green opsin promoter activity, which permits 
RGS9-1 overexpression in the inferior cones of MCV10. This speculation is consistent with the 
finding that all cones contain certain amount of M cone promoter activity, while S cone promoter 
activity is the strongest in the inferior hemisphere (Applebury, Antoch et al. 2000; Akimoto, 
Filippova et al. 2004). 
 Qualitatively, we have now established two transgenic lines overexpressing RGS9-1 in 
mouse cones. However, how much overexpression have we achieved in MCV9 and MCV10? 
Using the approach mentioned above, RGS9-1 staining was performed on the cross sections of T, 
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9T, 10T and 910T retinas to compare their intensities. We normalized the cone signal to that of 
neighboring rods on single optical slice of 0.39 µm. In the control retina (T), RGS9-1 is 1.8 fold 
higher in cones over rods in both the superior and inferior hemisphere (Figure 2.2A, B, ‘T’). In 
the 9T animal (MCV9 in T), cone RGS9-1 is 1.9 and 2.7 fold higher than rod in the inferior and 
superior hemispheres, respectively (Figure 2.2A, B, ‘9T’). In the 10T animal (MCV10 in T), 
cone RGS9-1 is 4.8 and 4.2 fold higher than rod in the inferior and superior hemispheres, 
respectively (Figure 2.2A, B, ‘10T’). By crossing MCV9 and MCV10 together (910T), cone 
RGS9-1 is 5.4 and 4.2 fold higher than rod in the inferior and superior hemispheres, respectively 
(Figure 2.2A, B, ‘910T’). By normalizing the overexpression level of RGS9-1 in 9T, 10T and 
910T to the control cone (T), inferior and superior cones have 1.1 and 1.6 fold higher in 9T, 2.7 
and 2.4 fold higher in 10T, and 3.0 and 2.4 fold higher in 910T, respectively (Figure 2.2C). 
Using transgenesis, we have established that the cones of 910T have 3-fold higher level of GAP 
complex than wild-type cones.   
RGS9-1 immunoquantification on flat-mount retina 
 Using IHC, we quantified the level of RGS9-1 overexpression in our transgenic animals. 
It is understandable that immunofluorescence may generate high variation in quantification due 
to sample preparation, quenching efficiency, oxidation, and staining variation. To minimize any 
artifact, all samples were processed at the same time and confocal images were taken 
immediately after staining. Furthermore, we decided to quantify RGS9-1 level on flat-mount 
retina in addition to retinal cross sections and normalized the cone RGS9-1 fluorescent intensity 
to rod signal. In control (T) flat-mount retina, cone RGS9-1 is 1.4 fold higher than rod (Figure 
2.3, ‘T’). In the transgenic animals, cone RGS9-1 in the inferior and superior hemispheres is 
express at 1.7 and 2.5 fold higher in 9T, 2.7 and 2.4 fold higher in 10T, and 3.9 and 3.1 fold 
higher in 910T than rod, respectively (Figure 2.3B). In addition, the level of overexpression was 
obtained by normalizing to control cone signal (T). Relative to wild-type cone, inferior and 
superior hemispheres of 9T have 1.2 and 1.8 fold higher expression of RGS9-1, 10T have 1.9 
and 1.7 fold higher expression, and 910T have 2.7 and 2.2 fold higher expression, respectively 
(Figure 2.3C). Overall, immunoquantification on flat-mount retina has slightly lower expression 
than the results from retinal cross sections. The quantification determined on flat-mount retina 
may be more reliable since it is possible to encircle and capture the RGS9-1 immunofluorescence 
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of cone and rod photoreceptors on single optic slice. The overexpression level determined on 
flat-mount retina will be used in this study to determine whether increasing RGS9-1 level in cone 
photoreceptor will speed up its recovery. 
Transgenic overexpression of RGS9-1 in a ‘cone-like’ retina of Nrl-/- mouse 
 While immunoquantification of RGS9-1 on retinal sections and flat-mount retina 
revealed GAP overexpression in MCV9 and MCV10 transgenic animals, it is possible, to 
corroborate this finding by checking RGS9-1 overexpression in the so-called ‘cone-like’ retina of 
Nrl-/- animals. The photoreceptors in the Nrl-/- retina resemble closer to cones than rod, as 
demonstrated by an upregulation of cone-transducin (GNAT2) and the absence of rod-transducin 
(GNAT1) (Figure 2.4A). By crossing the MCV9 and MCV10 transgenes into Nrl-/- animals, 
retinal RGS9-1 levels in the resulting animals with expression driven by the blue and green opsin 
promoter were found to increase (Figure 2.4). After quantification, RGS9-1 levels in MCV9 and 
MCV10 are overexpressed by 3-fold and 4.2-fold, respectively, compared to control Nrl-/- retina. 
We found a similar and expected increase in Gβ5 levels correspondingly by 2.7-fold and 3.5-fold 
in MCV9 and MCV10 animals, respectively (Figure 2.4B). As a negative control, the Gβ5-S 
levels are the same across all animals analyzed. Gβ5-S is not found in mouse photoreceptor and 
hence does not increase when R9AP is overexpressed in them. The fold of increase in RGS9-1 
level is higher in Nrl-/- background (by Western) than in WT background (by 
immunofluorescence). We have no explanation why, but would like to point out that while both 
determination methods have their own shortcomings (see below for Nrl-/- background), one 
consistent finding is that we do indeed generate transgenic mouse lines with elevated RGS9-1 
levels in cones of both MCV9 and MCV19 transgenic animals. 
While cone-specific RGS9-1 overexpression in MCV9 and MCV10 is confirmed in Nrl-/- 
background by immunoblot analysis, the conclusion has a few caveats. First, Nrl-/- 
photoreceptors have been reported and confirmed in our hand that they undergo a slow age-
dependent degeneration. Analysis of a six-month old MCV9 animal in Nrl-/- background reveals 
a decrease in cone-transducin, most likely due to photoreceptor degeneration (Figure 2.4A, lane 
4). The degeneration in Nrl-/- photoreceptor complicates the data interpretation while studying 
the biochemical and physiological properties derived from Nrl-/- animals. Second, the RGS9-1 
level in Nrl-/- photoreceptor is 50% less than that of WT level (Figure 2.4A, lane 1, 2 and 7), 
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which is unexpected and puzzling. As previously published results and further analyzed in this 
study, WT cone RGS9-1 level is higher than rod. This is not the case in the ‘cone-like’ 
photoreceptor in the Nrl-/- animals, suggesting that these cells are different from WT cones. Due 
to these concerns encountered, we decided to abandon any further analysis involving Nrl-/- 
background.   
Western analysis of mouse cone RGS9-1 level 
 Can we overcome the difficulty of quantifying protein levels in mouse cone due to its 
scarcity in the retina?  Furthermore, can we reliably quantify the level of protein that is expressed 
in both rod and cone, such as the GAP complex?  One approach that immediately comes to mind 
is to label mouse cone genetically by a fluorescent protein such as EGFP. If an animal like that 
can be made, one can dissociate the retina, isolate enough fluorescently labeled cones and 
perform Western blotting for protein quantification. To do so, we have recently generated several 
transgenic mouse lines called GGFP using the construct shown in Figure 2.5A.  One of them, 
GGFP-C, displays homogeneous cone labeling across retina (Figure 2.5B and C). This line may 
be used in future experiments attempting to assess the level of any protein in mouse cones. For 
proteins that are expressed in both rod and cones, it is possible to examine the level of expression 
in cone if expression in rod can be selectively removed. To achieve this, we take advantage of 
the fact that RGS9-1 and Gβ5-L are obligate partners in vivo and that knocking out Gβ5-L 
eliminates RGS9-1 level. Therefore by removing one of the two obligate partners in rod 
photoreceptor, the level of RGS9-1 in cones can be examined by quantitative Western blotting. 
In the lab, Dr. Jason Chen has successfully flanked the Gβ5 gene in the so-called Gβ5F/F mice. 
By crossing Gβ5F/F mice into the iCre75 background, in which a codon-improved Cre-
recombinase (iCre) is specifically expressed in rod photoreceptors, Gβ5-L can be conditionally 
removed from rods (Figure 2.6B). To enable Western blotting determination of RGS9-1 level in 
cones of MCV9 and MCV10 transgenic animals, we mated MCV9 and MCV10 into the R9AP-/- 
background, which remove the endogenous RGS9-1 in both rod and cone and reveal only the 
transgenic cone RGS9-1 level (Figure 2.6B). We have obtained data to show that this strategy 
works. In the 10R9AP-/- retina (MCV10 in R9AP-/-), the transgenic RGS9-1 is specifically 
expressed in mouse cones, as confirmed in IHC by PNA co-staining (Figure 2.6C). This data 
shows that the RGS9-1 detected by Western blotting from 10R9AP-/- retina is derived 
48
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exclusively from cones. For quantification purpose, RGS9-1 level in iCre75/Gβ5F/F animal is 
considered as WT cone level. Comparing 10R9AP-/- and iCre75/Gβ5F/F animals, the RGS9-1 and 
Gβ5-L expression is found to have increased by 4.5-fold and 10-fold in 10R9AP-/- retina. In 
R9AP-/-, the endogenous RGS9-1 and Gβ5-L protein expression are abolished. Therefore, the 
actual RGS9-1 and Gβ5-L overexpression of the MCV10 transgene is adjusted to 5.5-fold and 
11-fold over WT cones. The characterization of MCV9 and MCV910 in R9AP-/- background is 
currently underway, so is the determination of GAP level in R9AP+/- line in the iCre75/Gβ5F/F 
background. We envision that this strategy will most likely produce the most reliable quantitative 
data for us to establish a titration of RGS9-1 level in cones and the degree of recovery 
acceleration (see below). 
Analysis of Cone ERG recovery using cone-derived B wave responses 
 Before single cone recording is established using suction-pipettes, cone recovery is 
analyzed by using a double-flash ERG protocol (Figure 2.6A). A test flash of 1.63 log cd S/m2 is 
applied on a light-adapted mouse and after a specific interstimulus interval (ISI) from 100 to 
2000 ms, the same flash is applied and the remaining cone response is recorded. The response 
from the second flash is indicative of the cone recovery from the first flash. Normalizing to the 
maximal response and plotting the response recovery to the ISI, a recovery curve is obtained 
(Figure 2.7A). By fitting the recovery curve with the exponential equation, , two 
parameters, t0 and τ, are obtained. τ is the time constant of the recovery curve, whereas t0 is the 
critical time in which there is no recovery (the x-intercept). By performing the double flash ERG 
on T, 9T, 10T, and 910T animals, a smaller T0 is observed in all the RGS9-1 overexpressing 
animals. The critical time in T is 91.2 ms and is decreased to 76 and 73 ms in 9T and 10T, 
respectively. The t0 is further decreased to 55 ms in 910T, suggesting the additive effect of the 
RGS9-1 overexpression from both transgenes. The smaller the critical time, the faster the cone 
has recovered and stays in saturation for a shorter period of time. In addition, the presence of 
MCV7 transgene in 9T and 10T animals does not further decrease t0.  
RGS9-1 overexpression causes faster cone recovery (performed by Dr. Lihui Cao) 
f (x) = 1! e
x! t0
"
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 Cone-derived ERG b-wave response is not a direct measurement of cone photoresponse.  
Measuring cone ERG a-wave, which is a direct measure, is difficult and subject to great 
variability due to the rarity of cones in mouse retina.  To accurately measure cone 
photoresponses, we have worked with Dr. King-Wai Yau’s lab at the Johns Hopkins University.  
Dr. Lihui Cao, who is a postdoctoral fellow in Dr. Yau’s lab, works closely with us and uses a 
cutting-edge retinal slice recording technique to record photoresponses from cones.  In retinal 
slice recordings, a loose seal is first established by pulling in several nuclei, including the IS, into 
the recording pipette, as shown in Figure 2.8A. A background light strong enough to saturate 
rods but dim enough to leave a fraction of cones unstimulated is then turn on, followed by a flash 
of varying intensity to stimulate cone responses.  Dr. Cao reported to us that response amplitude 
and recovery kinetics recorded this way varied greatly, presumably because of the health of the 
retinal slices and the effect of background illumination needed to saturate rods. We then decided 
to mate all of our animals into the GNAT1-/- animals, in which rod transducin gene is deactivated 
and hence rod response is genetically removed, to simplify this rather difficult and time-
consuming recording procedure (Figure 2.8B). This improvement allows us to obtain reliable 
cone responses with light stimulus at 380 nm with intensity ranging from 1504, 3500, 6660, 
22500, 70500, 140000, 340000, 850000 photons µm-2. Plotting the response amplitude vs. flash 
intensity, the sensitivity, which is the intensity that produces a half-maximum response, is 
obtained (Figure 2.8C). Furthermore, two recovery time constants (τrec and τD) can be extracted 
by analyzing the recovery phase of the response waveforms in dim and bright flash. The 
dominant recovery time constant (τD) is determined by Pepperberg plot by fitting the time to 
40% recovery vs. flash intensity with a linear function to obtain its slope (Figure 2.8D). For τrec, 
the falling phase of dim flash response is fitted with an exponential equation to obtain the time 
constant (Figure 2.8E).  
 When recording is performed on 910T cones to assess the effect of RGS9-1 
overexpression on cone recovery kinetics, an accelerated recovery is easily seen as compared to 
T (Figure 2.9). The τD in 910T is 30.6 ms, compared to 64.3 ms in T cones (Figure 2.9C and D; 
Table 2.2). The smaller τD (faster recovery) in 910T confirms that the GTP-hydrolysis of cone 
transducin rate-limits the recovery of cone phototransduction. Similarly, τrec is decreased to 22.2 
ms in 910T, compared to 37.0 ms in T cones (Figure 2.9E and F; Table 2.2). In addition to the 
recovery kinetics in T and 910T, the τD from R9AP+/- cones is determined to be 93 ms in the 
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presence of background light. The τD of 93 ms in R9AP+/- is probably influenced by light 
adaptation, which has been shown to speed up recovery in photoreceptors.  To obtain a more 
accurate measure, we also mated R9AP+/- into the GNAT1-/- background and cone recordings in 
R9AP+/-T (R9AP+/- in GNAT1-/- background) animal reveals a τD of 131 ms (data not shown). 
Using the quantification on flat-mount retina and values of τD in R9AP+/-, T, and 910T, an 
exponential function can be fitted to our data set (Figure 2.9G) that reveals an asymptote τD 
value of  ~25 ms when RGS9-1 is overexpressed in cones. To further prove that the acceleration 
of cone recovery can be pushed to reach the asymptote, we produce homozygous transgenic 
animals with two copies of MCV9 and/or MCV10 transgene. Recordings from the cones of these 
animals show highly variable response amplitudes or in some cases, no responses at all. IHC 
analysis on retinal sections of these animals then revealed that cones in the so-called 99T and 
1010T mouse retinas degenerate as the number of PNA-positive cells are significantly decreased 
(Figure 2.9H).  This data suggest that overexpression of RGS9-1 may cause cone degeneration, 
or that both transgenes were inserted into loci that contains genes essential for cone survival. 
Despite the obvious drawback, the acceleration in cone recovery observed in the 910T animals 
confirms our ERG analysis that GTP-hydrolysis of cone transducin rate-limits the recovery phase 
of cone phototransduction.  
The generation and distribution of human GRK7-expressing cones in MCV7 and MCV8 
transgenic mouse lines 
 To test the effect of increasing GRK level on the recovery of cone photoreceptor, human 
GRK7 expression is specifically expressed in mouse cones using the blue opsin and green opsin 
promoter (Figure 2.1B). Human GRK7 is used to increase the GRK activity in mouse cones 
instead of bovine GRK1 for the following reasons: (1) GRK7 is a superior kinase than GRK1 
and (2) since GRK7 is not expressed in mouse, its transgenic expression can be easily identified 
without any endogenous protein influence. To confirm GRK7 expression in mouse cone 
photoreceptor, IHC staining is performed on the retinal section of MCV7 and MCV8 transgenic 
animals with the Y722NP antibody (the characterization of Y722NP antibody is described in 
Chapter 3). In both transgenic lines, GRK7 expression is specific to mouse cone photoreceptor 
and found in COS, as demonstrated by the presence of the kinase surrounded by the cone marker, 
PNA (Figure 2.10A). The GRK7 expression in MCV7 and MCV8 has distinct distribution 
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profile. Base on the ratio of GRK7 to PNA, GRK7 expression in MCV7 is present in 96% of the 
cones in the inferior hemisphere and in 35% of the cones in the superior hemisphere (Figure 
2.10B). In contrast, GRK7 expression in MCV8 is distributed homogeneously in both the 
superior and inferior hemispheres at 88%. With MCV7 and MCV8 transgenic mice, the GRK 
activity in mouse cone photoreceptor can be increased. 
Exploring the potential of cone pigment deactivation mediated by GRKs as the second rate-
limiting step in cove recovery 
 With the 910T animals, we have shown that RGS9-1 overexpression can accelerate the 
recovery of cones. This soundly establishes that cone-transducin turn-off rate-limits cone 
recovery. As a complementary approach and a control to this finding, we also sought to test the 
effect of overexpressing GRKs in mouse cone recovery by expressing human GRK7 in cones of 
MCV7 and MCV8 transgenic animals (Figure 2.10). Initial characterization of MCV7 and 
MCV8 transgenic animals is described in Chapter 3. For cone recovery, MCV7 is first mated 
into GNAT1-/- to generate 7T and to assess its cone recovery. The τD and τrec are 62.1 and 45.8 
ms in the 7T cons (Figure 2.11 and Table 2.2), which is similar to the 64.3 and 37.0 ms obtained 
for cones of the transducin knockout animals (Figure 2.9). The lack of recovery acceleration 
between the two types of cone suggests that cone opsin phosphorylation may not be the rate-
limiting step of mouse cone recovery. We then sought to determine whether opsin deactivation 
might be the second slowest step in cone recovery using the 7T and 8T animals. In a condition 
when RLS is accelerated enough that it is no longer the slowest step, the second slowest step 
may determine the overall rate of cone recovery. Currently, we have not discerned whether the 
level of RGS9-1 overexpression in 910T cones has been elevated enough to allow us to study the 
second slowest step. As mentioned earlier, further attempts in increasing RGS9-1 level beyond 
910T result in cone degeneration (Figure 2.9H). Also, based on the fit in Figure 2.9G, the 
recovery in 910T has not reach the asymptotic value of 25.1 ms. To test whether opsin 
deactivation becomes rate-limiting in 910T cones, the recovery time constants between 7910T 
and 910T cone responses are compared. The τD and τrec are 33.0 and 25.4 ms in 7910T cones, 
respectively, and they are not significantly different from the 30.6 and 22.2 ms of 910T cones 
(Table 2.2). We conclude that opsin phosphorylation by GRKs may not accelerate cone recovery 
in 910T. Since it cannot be determined whether the recovery in 910T has reached the rate of the 
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second RLS, the termination of cone opsin as the second slowest step in cone recovery remains a 
possibility. 
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Discussion 
 The blue and green opsin promoters are used in this study to overexpress RGS9-1 and 
GRK7 in the two types of mouse cones. RGS9-1 overexpression can be established by 
overexpressing R9AP, indicating that similar to rod, R9AP concentration controls the level of the 
GAP complex in cone. On the other hand, GRK7 is used to increase the overall GRK activity in 
cones because it is a superior kinase in-vitro. The fact that mouse as a species lacking a GRK7 
gene facilitates the detection of the transgenic GRK7 expression in our mouse lines. Based on the 
design, MCV7 and MCV9 should drive GRK7 and RGS9-1 expression in mouse S cones with 
the blue opsin promoter, whereas MCV8 and MCV10 should drive GRK7 and RGS9-1 
expression in mouse M cones with the green opsin promoter. The S and M cones make up the 
3% of photoreceptor in mouse retina. Due to the rarity of cones, IHC on retinal cross section is 
used to determine the overexpression of RGS9-1 and the expression of GRK7 in the transgenic 
cones. The expression pattern of transgenic RGS9-1 and GRK7 is dependent on the type of the 
cone opsin promoter because S and M cones are found to have distinct localization in mouse 
retina. Using the blue opsin promoter, the overexpression of RGS91 and GRK7 expression in S 
cone are concentrated in the inferior hemisphere and decreased towards the superior hemisphere. 
In contrast, the protein expression in M cones is distributed across the superior and inferior 
hemisphere with slightly higher level in the superior cones. The S cones in the inferior region 
contain both blue and green opsin promoter activity, whereas the ones in the superior region 
contain mostly green opsin promoter with fewer blue opsin promoter activity. Using the blue and 
green cone opsin promoters, the overexpression of the GAP complex and GRKs is established in 
mouse cone photoreceptors.  
 As mentioned, the low number of cones makes it difficult to quantify the level of RGS9-1 
overexpression in MCV9 and MCV10 compared to WT cones. However, since the 
overexpression of RGS9-1 is detectable on retinal sections, the immunofluorescence signal of the 
cone RGS9-1 is normalized to rod level and quantified accordingly. Furthermore, the same 
RGS9-1 quantification is carried out on flat mount retina. In WT, the RGS9-1 expression in cone 
is 1.8 and 1.4 fold higher than rod on retinal section and flat-mount retina, respectively. The 
quantification is slightly variable, which can be attributed to the penetration capacity of the 
CT318 antibody between cross section and flat-mount retina. Averaging the two quantifications, 
the WT cone RGS9-1 is 1.6-fold higher than rod, which is significantly lower than the estimated 
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10-fold increase in RGS9-1 in chipmunk with a cone-dominant retina. This difference in the 
quantification of RGS9-1 level in cone and rod can be partially attributed to species variation. 
Revisiting the study by Cowan et al., the RGS9-1 intensity in chipmunk and mouse retina is not 
the same between rod and cone, suggesting that the fold of RGS9-1 overexpression in chipmunk 
may not reflect the same overexpression in mouse retina (Cowan, Fariss et al. 1998). In addition, 
the determination in chipmunk may be an overestimation. Only 75% of the photoreceptors in 
chipmunk are cones, suggesting that the RGS9-1 quantified on Western blot has significant 
contribution from chipmunk rods. On the other hand, there are many known caveats on using 
immunofluorescence to quantify protein expression. Among them, it is possible that the staining 
may not be within linear range, which may cause the cone signal to saturate and underestimate 
the cone RGS9-1 quantification. While the linear range of CT318 (anti-RGS9-1 antibody) on 
IHC is not established in this study, immunostaining and image acquisition are performed 
simultaneously to minimize variations between experimental conditions. The higher level of 
RGS9-1 in MCV9 and MCV10 suggests that the condition used in IHC is not saturated, but it 
does not indicate that the quantification is performed in the linear range. Therefore, we settle for 
a RGS9-1 level in wild-type mouse cones as 1.6-fold higher than rod, which is much lower than 
the conventional wisdom. 
 While quantification by IHC has its own bias and we cannot really conclude with 
certainty beyond having made mouse lines with overexpressed RGS9-1 in cones, alternative 
means are deemed necessary if we are to obtain the actual level of overexpression in these mouse 
cones. We have finally found two alternative ways to achieve this quantification. First, using the 
‘cone-like’ retina of the Nrl-/- mice, the RGS9-1 overexpression in the MCV9 and MCV10 
transgenes is confirmed and quantified to be 3 and 4.2 fold. The RGS9-1 signals are derived 
purely from the ‘cone-like’ photoreceptor and there is no rod signal contamination in Nrl-/- 
background. The fold of transgene overexpression in Nrl-/- background is two times higher than 
the immunofluorescence quantification. However, we have less confidence in this method 
because in Nrl-/- background, these ‘cone-like’ photoreceptors adopt an enhanced S cone identity 
and hence the quantification may not correlate with the overexpression in WT background. 
Furthermore, the slow degeneration in Nrl-/- may reduce the level of RGS9-1 depending on 
mouse age when the determination is made. Second, removing the endogenous RGS9-1 with 
R9AP-/- or the RGS9-1 in rods using the rod-specific Cre-recombinase to deleted the rod GAP 
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complex (iCre75, Gβ5Flox/Flox), the RGS9-1 expression in cone photoreceptor can be 
determined and quantified with immunoblot. Surprisingly, the RGS9-1 expression from MCV10 
transgene is 5.5 fold higher than WT cone, about two times higher than the immunofluorescence 
quantification. Further experimentation is required to ensure that no leaky transgene expression 
is presented in the rods of MCV10 animals. The quantification in R9AP-/- and iCre75/Gβ5F/F 
animals seems to be a superior method than using Nrl-/- animals because morphology of R9AP-/- 
and iCre75/Gβ5F/F cones resemble more closely to that of WT cones. One consistent finding 
using Western blot to quantify the RGS9-1 level in MCV9 and MCV10 is that the fold of 
overexpression is two times higher than using immunofluorescence. It is possible that the 
immunofluorescence quantification is off by a factor of 2. Whether protein quantification using 
immunofluorescence is lowered by a factor of two may be assessed with further controls by 
comparing rod with known RGS9-1 overexpression. Since the quantification in R9AP-/- and 
iCre75/Gβ5F/F is still ongoing, in this thesis, the immunofluorescence data is used to correlate the 
RGS9-1 overexpression and its effects on cone recovery. 
 Our experimental design allows us to combine MCV9 and MCV10 transgenic lines 
together in 910T to achieve a higher level of RGS9-1 overexpression in cones, which is 
determined to be 3- and 2.7-folds base on quantification on retinal section and flat mount retina, 
respectively. Functionally, cones with higher RGS9-1 concentration have faster recovery 
compared to WT cones. The MCV9 and MCV10 animals are crossed into GNAT1-/- background 
to eliminate rod phototransduction. The identification of cone responses is facilitated in the 
GNAT1-/- background. More importantly, no background light is needed to pre-saturate rod 
responses before recording cone, thus preventing complications associated with light-induced 
recovery acceleration. The recovery of cone photoreceptor is assessed with ERG and single cell 
recording, the former is non-invasive but indirect and the latter is direct but invasive. With 
double flash ERG, the cone-derived B wave response is used to assess cone recovery. Fitting the 
normalized recovery curve with a single exponential equation, the critical time (t0), the time in 
which cone responses remain unrecovered, can be determined. Smaller t0 suggests faster 
recovery. Compared to WT, cone recovery in 9T and 10T are equally accelerated and further 
speed up in 910T cones, suggesting the additive effect of RGS9-1 overexpression in 910T to 
further increase cone transducin deactivation. The acceleration observed in cones with higher 
RGS9-1 concentration lends strong support to the notion that GTP-hydrolysis of cone transducin 
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may be the rate-limiting step in cone recovery. While double flash ERG recording confirms the 
faster recovery in cones with RGS9-1 overexpression, the smaller t0 derived from double flash 
ERG is not a direct measurement of cone recovery since the recovery curve is generated from the 
cone-derived bipolar cell response. To directly measure the recovery of cone photoreceptor, 
suction recordings are performed on isolated retinas from T, 9T, 10T and 910T animals. Cone 
recordings demonstrated WT cones recovery is accelerated in 910T with 2.7-fold RGS9-1 
overexpression. The recovery time constants in dim flash and bright flash responses are both 
sped up to 31 and 22 ms, respectively, in cones with higher GAP concentration, confirming that 
cone transducin deactivation dictates the recovery phase in cone phototransduction in all ranges 
of light intensities. While 2.7-fold increase in RGS9-1 concentration can speed up cone recovery, 
it is unknown whether the τD of 31 ms in 910T cones reflects the boundary in which the cone 
transducin deactivation is sped up enough that the second cone RLS becomes the slowest step. 
Fitting the dependence of cone recovery time constant to the fold of RGS9-1 concentration, we 
obtain a theoretical upper limit in cone recovery as 25.1 ms. If the upper limit of cone recovery 
has been reached, then increasing RGS9-1 concentration beyond 910T shall have little or no 
influence on the τD of cone recovery. However, the attempts to further increase RGS9-1 level by 
generating multiple copies of transgene (99T, 1010T, 9910T, 91010T, and 991010T) result in an 
unexpected and disappointing cone degeneration phenotype, which in most cases can be seen as 
early as one month of age. This degeneration suggests that by increasing the deactivation of cone 
transducin, an unknown mechanism is triggered that leads to cone apoptosis. It is possible that 
the degeneration is mediated through the increase of R9AP, Gβ5-L, RGS9-1, or any combination 
of these proteins, which pinpoints to an unknown role of the GAP complex in maintaining 
photoreceptor health. It is difficult to discern which GAP component is the trigger of cell 
degeneration. Also, it is unknown whether this cone degeneration is light dependent and further 
studies are required to determine if dark adaptation or removing cone phototransduction can 
prevent cone death. This is not the first report in which photoreceptor degeneration is observed in 
genetically modified photoreceptors. In mice without GRK1 and/or arrestin, photoreceptors 
degenerate due to prolonged rhodopsin activation. Also, rods with overexpressed GRK1 
degenerates in the presence of bright light, suggesting that early recovery may lead to 
photoreceptor degeneration (However, a BAC construct was used to overexpress GRK1 and may 
cause side effects depending on the integration site and the content of the construct). While it is 
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evident that higher RGS9-1 (>3-fold) expression causes cone degeneration, the mechanism by 
which apoptosis is triggered in cone photoreceptor requires further investigation. 
As cone recovery is rate-limited by the deactivation of cone transducin, cone opsin 
phosphorylation by GRKs must occur faster than the GTP-hydrolysis of cone transducin. 
Therefore, increasing GRK activity should not affect the recovery time constants in cone 
phototransduction. In this study, GRK7 is used to increase the opsin phosphorylation. However, 
since GRK7 is not present in mouse genome, it is essential to confirm that GRK7 is indeed 
functional in mouse cones, which will be described in detail in the following chapter. Suffice it 
to say that GRK7 is confirmed to be functional in mouse cone photoreceptors; the effect of 
increasing GRKs on cone recovery can be assessed. Single cell recording on 7T cones shows 
those cones with GRK7 expression has similar τD and τrec compared to T cones. The generation 
of the 8T animals is underway and will be characterized in the similar manner. The recovery in 
8T cones is expected to be similar to 7T and T cones. The similar recovery observed between 
GRK7-expressing cones and WT cones demonstrates that cone opsin deactivation is not the RLS 
in cone recovery. Possibilities remain that the cones recorded in 7T animals may not contain 
GRK7 expression since the kinase expression is concentrated in the inferior hemisphere in 
MCV7. To minimize recording from non-GRK7 expressing 7T cones, cones are selected from 
the inferior region. Cone recording from 8T or 78T can further solidify the point that cone opsin 
phosphorylation by GRKs does not rate-limit the recovery of cone phototransduction.  
As cone opsin phosphorylation by GRKs is not the slowest step in cone recovery, 
however, it may be the second slowest step. To test this, the recovery time constants of 910T and 
7910T cones are compared. If cone transducin deactivation is sped up enough that the second 
RLS becomes the slowest step, then increasing the enzyme level for the second RLS can further 
accelerate cone recovery. Therefore, if 910T cone with 2.7-fold of RGS9-1 overexpression and a 
recovery time of 31 ms is the fastest that the first RLS can be sped up, then the second RLS can 
be studied. By overexpressing GRKs in 910T cones (7910T), cone opsin deactivation is 
increased under the condition in which cone transducin turnoff is accelerated. In 7910T cones, 
the τD and τrec is similar to 910T, suggesting that cone opsin phosphorylation is not the second 
slowest step in cone recovery. However, this interpretation has a few caveats. It is not established 
that the deactivation of cone transducin in 910T cones has sped up to become faster than the 
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second RLS. Therefore, the lack of recovery acceleration in 7910T may be because the GTP-
hydrolysis of cone transducin is still the slowest step in recovery in 910T cones. Due to the cone 
degeneration induced by early recovery, it may be difficult to assess the second RLS in cone 
recovery until further manipulations can prevent the apoptosis in cone photoreceptors.  
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Conclusion 
It has been determined that transducin deactivation rate-limits the recovery of mouse rod 
phototransduction because by increasing the concentration of the GAP complex, rod recovery 
can be accelerated from ~200 ms to as fast as 54 ms. Rod and cone share some, while possessing 
distinct cell-specific phototransduction components, it is unknown whether the identity of RLS 
in rod recovery also applies to cone. Higher level of the GAP complex in cones of many species 
should conceivably contribute to a faster recovery time course and it has the potential to alter the 
identity of the RLS in cone recovery. However, an additional kinase, GRK7, is also co-expressed 
with GRK1 in the cones of certain species, which increases the kinase activity in cone 
photoreceptors. Such a higher kinase level may also promote a faster opsin phosphorylation and 
may contribute to accelerate recovery in cone phototransduction. Altogether, it is not an easy 
task to predict which might be the actual slowest step in cone photoreceptor recovery. The 
success of using a GOF approach by either overexpressing RGS9-1 or GRKs to reveal the RLS 
of cone phototransduction recovery has been adopted here and unequivocally identified that cone 
transducin deactivation is indeed the slowest step during the recovery of cone phototransduction. 
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CHAPTER 3 
The Role of GRKs in Oguchi Disease 
Introduction 
The activity of G-protein-coupled-Receptor Kinase 1 (GRK1) was first described in the 
light-dependent phosphorylation of rhodopsin in the outer segment (OS) of rod photoreceptors 
(Bownds, Dawes et al. 1972; Kuhn and Dreyer 1972; Frank, Cavanagh et al. 1973). As GRK1 
was unstable and sensitive to biochemical manipulations, isolating it in sufficient quantity and 
good quality was difficult despite attempts from many labs over a period of 30 years (Maeda, 
Imanishi et al. 2003). The GRK1 gene was cloned in the early 90s (Lorenz, Inglese et al. 1991; 
Zhao, Haeseleer et al. 1997), and since then many important findings have elucidated GRK1’s 
roles in phototransduction recovery, light and dark adaptation, and in stationary night blindness 
of human Oguchi disease. GRK1 is post-translationally modified by isoprenylation and 
phosphorylation. Furthermore, other signaling molecules, such as recoverin and protein kinase 
A, also regulate GRK1 function. Many data have been collected to show that GRK1 is essential 
for the deactivation of photoactivated rhodopsin and timely termination of rod and cone 
photoresponses. However, the intermolecular interactions between GRK1 and visual pigments 
were not clear until recently when the GRK1 crystal structure was solved and provided further 
insight. We summarize here recent discoveries on GRK1 and its regulation and function in 
retinal photoreceptors. Questions that need further attentions will also be discussed. 
G-protein-coupled receptors (GPCR) with heptahelical transmembrane domains are a 
large group of cell surface proteins enabling a cell to sense its environment by coupling to 
heterotrimeric G-proteins. A wide range of physiological processes such as senses, hormonal 
actions, and neurotransmission employ GPCRs. The termination of GPCR signaling requires a 
protein family known as G-protein-coupled-receptor kinases (GRKs), which phosphorylate 
activated GPCR and are responsible for homologous desensitization. GRKs belong to the family 
of Serine-Threonine protein kinases and phosphorylate C-terminal serine and threonine residues 
located at C-terminal tails of activated GPCRs. Following receptor phosphorylation, the 
interaction with G-protein is weakened, and a subsequent binding of arrestin to phosphorylated 
receptors completely prevents them from coupling to G-proteins. In most non-photoreceptor 
cells, arrestin binding initiates receptor endocytosis to prolong and enhance desensitization (Dorn 
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2009). Controlling GPCR activity by this simple and elegant deactivation mechanism is 
important for many cellular responses, as loss-of-function mutations in GRKs have lead to a 
variety of pathologic conditions.  
There are seven members in the GRK family that can be further subdivided into three 
groups: GRK1-like, GRK2-like, and GRK4-like. GRK1-like group consists of GRK1 and GRK7, 
which are expressed specifically in retinal photoreceptors. GRK2-like group contains GRK2 and 
GRK3, which are ubiquitously expressed. GRK4-like group is comprised of GRK4, GRK5 and 
GRK6. GRK4 expression is restricted to kidney, cerebellum, and testis, while GRK5 and GRK6 
are expressed ubiquitously. All GRKs share a central kinase domain of approximately 270 amino 
acids, typical to that of other Ser/Thr kinases. The N-terminus of GRKs contains an RGS 
Homology (RH) domain, which is found in Regulators of G-protein Signaling (RGS) proteins 
(Ribas, Penela et al. 2007; Dorn 2009). The RH domain of GRK1 and GRK2 has ~20-25% 
homology to that of the R7 subgroup of RGS proteins (data not shown). GRK2 has been shown 
to interact with Gαq family through its RH domain, but with low GTPase accelerating protein 
(GAP) activity (Ribas, Penela et al. 2007). The physiological function of GRK1 RH domain 
remains unclear. The C-terminal regions of GRKs are most dissimilar with varying sizes and 
different protein motifs that contribute to the diversity of GRKs. GRK2 is critical in cardiac 
physiology, as its inactivation leads to cardiac abnormality and embryonic lethality in mice 
(Dorn 2009). GRK1 and GRK2 are the most extensively studied GRK members. GRK1 is 
required for visual pigment deactivation in rod and cone (Chen, Burns et al. 1999; Lyubarsky, 
Chen et al. 2000). The specific expression of GRK1 in retinal photoreceptors provides an 
opportunity to study GRK’s function under a physiological context and has been useful in 
understanding the general actions of other GRKs in eukaryotic cells. 
  GRK7, a close relative of GRK1, was cloned from mammalian species (Weiss, Raman et 
al. 1998) and quite interestingly, the expression patterns of GRK1 and GRK7 vary from species 
to species. GRK1 is expressed in both rod and cone photoreceptors, while GRK7 is expressed 
only in cones and not in rods of human (Chen, Zhang et al. 2001; Weiss, Ducceschi et al. 2001). 
In species such as pigs and dogs, their cones only express GRK7. In rodents, GRK7 is absent and 
both rods and cones rely on GRK1 for receptor deactivation. Studying the differences between 
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GRK1 and GRK7 has provided insights into the structure/function relationship of GRKs and the 
pathological mechanism of Oguchi Disease.    
Role of GRK1 in phototransduction, Oguchi Disease, and light-dependent degeneration 
Photoreceptors without GRK1 take a very long time to dark adapt. In GRK1-/- 
photoreceptors, receptor deactivation is so slow that it artificially becomes the slowest step 
during the recovery phase of rod and cone phototransduction (Chen, Burns et al. 1999; 
Lyubarsky, Chen et al. 2000). Inactivating one copy of GRK1 also causes a noticeable delay in 
rod recovery, suggesting that GRK1 level may be critical in setting the duration of rod’s 
photoresponses. However, while the loss-of-function approach clearly demonstrates the 
importance of GRK1 in rod recovery, it does not have the power to reveal whether R* 
phosphorylation dominates the recovery time course in normal rods. To determine whether a 
reaction is rate-limiting in a cascade of events, a gain-of-function approach such as increasing 
the concentration of the enzyme that catalyzes the slowest step is more appropriate (Nikonov, 
Engheta et al. 1998; Kennedy, Sowa et al. 2003). If rhodopsin deactivation rate-limits rod 
recovery, enhancing rhodopsin phosphorylation by overexpressing GRK1 should accelerate rod 
recovery. In Krispel et al., several transgenic lines with varying levels (up to four fold) of GRK1 
overexpression were made but the rods showed no statistically significant changes in the 
activation and deactivation phases to WT rods. These negative results suggest that rhodopsin 
deactivation is not the normal rate-limiting step in rod recovery. In fact, using a similar gain-of-
function approach where the ternary GAP complex of R9AP/Gβ5-L/RGS9-1 is overexpressed in 
rods, the recovery can be sped up. This indicates that transducin deactivation is the overall rate-
determining step in rod recovery (Krispel, Chen et al. 2006). In rods with four-fold increase of 
RGS9-1 concentration, the recovery time constants (τD and τrec) are decreased to 70 ms 
compared to 250 ms in WT rods. Recently, Chen et al. observed a recovery time constant of 54 
ms in rods with a six-fold increase of RGS9-1 overexpression, again significantly different from 
the 185 ms found for WT controls (Chen, Woodruff et al. 2010). With transducin turn-off as the 
slowest step, is rhodopsin deactivation the second slowest step in rod recovery? The criterion to 
reveal the second rate-limiting step is to sufficiently speed up transducin GTP-hydrolysis until 
the second step becomes the slowest step. Is the six-fold higher RGS9-1 overexpression enough 
to speed rod recovery to a point that the overall rate is now determined by the second slowest 
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step? If yes, the 54 ms time constant reflects how fast GRK1 can work on R*.  If not, one has to 
assume that GRK1 works even faster.  As a comparison, the recovery time constant of GRK1-/- 
rods is between 4,000 to 5,000 msec. Using GRK+/- or reconstitution GRK1-/- rods with lower 
amount of GRK1 (Chen, Woodruff et al. 2010), rod recovery can be modulated to be faster than 
GRK-/- but slower than WT rods. In a study by Doan et al., the recovery time of single photon 
response (SPR) in GRK+/- is twice that of WT rods. Similarly, the recovery time constants are 
increased (slower recovery) in rods with lower amounts of GRK1 in both dim and bright flash 
conditions. By reducing the level of the kinase, rhodopsin deactivation becomes slower than 
transducin deactivation during the recovery phase. In the condition where rhodopsin deactivation 
becomes rate-limiting, any manipulations that regulate rhodopsin lifetime may now be studied 
with single rod recordings. Recent demonstrations of studying SPR variability in GRK1+/-
/Arrestin1+/- rods and recoverin modulating rhodopsin lifetime during light-adaptation are 
examples of using rods with lower GRK1 level to study rhodopsin deactivation (Doan, Azevedo 
et al. 2009; Chen, Woodruff et al. 2010).  
 Proper shutoff of rhodopsin requires phosphorylation by GRK1, followed by arrestin 
binding. Recent study has proposed and demonstrated that the relative concentration between 
GRK1 and arrestin controls the kinetics of SPR by modulating rhodopsin lifetime (Doan, 
Azevedo et al. 2009). It has been shown that arrestin has a low-affinity towards 
unphosphorylated rhodopsin and may compete with GRK1 in rhodopsin binding during 
recovery. To demonstrate the competition, SPRs are recorded from GRK1+/- and GRK1+/-
/Arrestin+/- rods, in which the level of GRK1 and arrestin is decreased to below 50% of WT 
level. In rods with reduced GRK1, the recovery of the SPR is twice that of WT. When arrestin 
level is decreased in GRK+/- rods (GRK1+/-/Arrestin+/-), the recovery time is restored to WT 
level. These results suggest that decreasing arrestin favors GRK1 binding and its activity on R*. 
The competition between GRK1 and arrestin influences the time course of rhodopsin 
deactivation and controls the variability of SPR. It is interesting to note that in this study (Doan, 
Azevedo et al. 2009), rhodopsin deactivation time course is longer, whereas in other reports 
(Krispel, Chen et al. 2006; Chen, Woodruff et al. 2010; Gross and Burns 2010) transducin turn-
off is the slower reaction. It was speculated by Doan et al. that the differences between the two 
results can be attributed to the differences in Ames and Locke’s solutions. However, Gross et al. 
demonstrated that the acceleration in transducin deactivation through RGS9-1 overexpression 
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can be recapitulated in both Ames and Locke’s solutions. The reason for this puzzling 
discrepancy remains unclear.   
  Photoreceptor is susceptible to damage and degenerates in the presence of light delivered 
at high intensity or for a prolonged period (Hao, Wenzel et al. 2002). Genetic manipulation in 
mouse in recent years has identified several proteins that protect photoreceptors from light 
damage. One of them is GRK1. In the first report of the GRK1-/- mouse, outer segment defects 
and photoreceptor degeneration occur under regular vivarium lighting conditions and can be 
prevented by rearing them in total darkness (Chen, Burns et al. 1999). Photoreceptor lacking 
arrestin also displays light-induced OS defects and degeneration. In the double knockout (GRK1-
/-/Arrestin-/-) mouse, photoreceptor becomes extremely sensitive to light damage, which occurs at 
exposures as short as one minute (Choi, Hao et al. 2001; Hao, Wenzel et al. 2002; Krishnan, Lee 
et al. 2008). The susceptibility to light damage in GRK1-/-, Arrestin-/- and double knockout 
photoreceptors presumably arise from the prolonged activation of rhodopsin. The degeneration in 
these animal models has been shown to activate both transducin-dependent and transducin-
independent pathways to cause cell death (Hao, Wenzel et al. 2002; Fan, Sakurai et al. 2010). In 
the presence of bright light, photoreceptor without transducin still degenerates in a pathway that 
signals through activated rhodopsin. In contrast, the degeneration seen in GRK1-/- and Arrestin-/- 
photoreceptors under dim light condition is mediated by constant transducin activation. By 
mating these animals with GNAT1-/-, the degeneration under dim light can be prevented (Hao, 
Wenzel et al. 2002). These evidences showcase the protective properties of GRK1 and arrestin in 
rods against light-damage by timely rhodopsin deactivation.  
Since the loss of GRK1 leads to prolonged rhodopsin lifetime and cell death, can 
increasing GRK1 protect photoreceptor against degeneration? In the recent study by Whitcomb 
et al., BAC transgenic technique was used to overexpress GRK1 in rod photoreceptor to 
approximately three fold (GRK1+). Correspondingly, rhodopsin phosphorylation is also 
increased in GRK1+ rods. Retinal morphology in GRK1+ animals is similar to WT under regular 
illumination. However, when the animals are exposed to intense light (10,000 lux) for 12 hours, 
GRK1+ photoreceptors display faster degeneration (Whitcomb, Sakurai et al. 2010). These data 
are contrary to what one may expect because GRK1 overexpression does not provide protection 
against light-induced degeneration, instead, hyper-phosphorylation of rhodopsin may accelerate 
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an unknown signaling event that leads to cell death. GRK1 concentration apparently needs to be 
maintained optimally within photoreceptors as an increase or loss of GRK1 can accelerate light-
induced photoreceptor degeneration. While retinal degeneration has been described in many 
mouse strains in which they become useful models of human macular degeneration and retinitis 
pigmentosa, the cellular mechanisms that trigger apoptosis have been less well understood. 
Future studies are needed to determine the signaling pathway(s) leading from rhodopsin light 
absorption to photoreceptor cell death to shed light into these dark and debilitating human 
conditions.  
 It is evident from animal studies that the loss of GRK1 results in severe defects in 
photoreceptor function. Similarly, mutations in GRK1 and arrestin genes have been found in 
human patients suffering from Oguchi Disease, an autosomal recessive congenital stationary 
night blindness (CSNB). Oguchi Disease was first described in 1907 and is characterized with a 
unique fundus appearance of golden-grayish discoloration (Carr and Gouras 1965), which 
disappears after dark-adaptation for more than three hours. This fundus characteristic is termed 
Mizuo Phenomenon. It is observable under optical coherence tomography (OCT) that the 
distribution of the fundus discoloration coincides with the accumulation of activated rhodopsin at 
the shortened outer segment layer (Hashimoto and Kishi 2009). Color vision in Oguchi patients 
is typically normal, which indicates that cone function is unaffected. ERG analyses of Oguchi 
patients demonstrate severe delay in scotopic recovery and elevated rod thresholds, while their 
photopic responses are by and large unaffected (Carr and Gouras 1965; Cideciyan, Zhao et al. 
1998; Zhang, Zulfiqar et al. 2005). Various GRK1 mutations have been identified and are listed 
in Table 3.1. Ectopically expressing GRK1 with Oguchi mutations (V380D, Ser536 (4-bp del), 
and exon 5 deletion) in COS7 cells has demonstrated a reduced ability to phosphorylate R* 
(Cideciyan, Zhao et al. 1998; Khani, Nielsen et al. 1998). However, these mutations may also 
destabilize GRK1 in photoreceptors and this remains to be tested.  As losing kinase activity or 
protein expression lead to defective rhodopsin phosphorylation and a prolonged dark adaptation 
time in Oguchi disease patients, one interesting discrepancy is worth noting here. Mouse without 
GRK1 has severe recovery defects in both cone and rod, while cones of most Oguchi disease 
patients appear spared. This is because of the expression of GRK7 (Maeda, Imanishi et al. 2003) 
in human cones. It is also interesting to note that cone ERG responses are diminished in patients 
with P391H GRK1 mutation, suggesting that this particular mutation may have a dominant effect 
87
Ta
bl
e 
3.
1.
 G
R
K
1 
m
ut
at
io
ns
 in
 O
gu
ch
i D
is
ea
se
 r
ep
or
te
d 
to
 d
at
e.
 T
he
 li
st
 o
f G
R
K
1 
m
ut
at
io
ns
 th
at
 h
av
e 
be
en
 id
en
tif
ie
d 
cl
in
ic
al
ly
 in
 p
at
ie
nt
s w
ith
 O
gu
ch
i D
is
ea
se
.  
88
Ta
bl
e 
3.
1:
 G
R
K
1 
m
ut
at
io
ns
 in
 O
gu
ch
i D
is
ea
se
 r
ep
or
te
d 
to
 d
at
e 
Pa
tie
nt
 
M
ut
at
io
n 
Pr
ot
ei
n 
C
on
e/
R
od
 fu
nc
tio
n 
G
en
de
r/
A
ge
 
Fa
m
ily
 H
is
to
ry
 
R
ef
er
en
ce
 
#3
03
-3
01
 
Ex
on
 5
 d
el
et
io
n 
Fr
am
es
hi
ft 
m
ut
at
io
n:
 
pr
em
at
ur
e 
st
op
 c
od
on
 
N
or
m
al
/d
el
ay
 
m
al
e 
Je
w
is
h 
an
ce
st
or
 
H
un
ga
ry
/U
kr
ai
ne
 
(Y
am
am
ot
o,
 S
ip
pe
l e
t 
al
. 1
99
7)
 
#3
03
-3
02
 (C
as
e 
3:
 
N
IH
#0
3-
37
-3
3)
 
V
38
0D
, 
Se
r5
36
(4
bp
-d
el
) 
C
om
po
un
d 
he
te
ro
zy
go
us
 
(n
eg
at
iv
e 
ch
ar
ge
 in
 
ca
ta
ly
tic
 d
om
ai
n/
lo
ss
 o
f 
la
st
 2
2 
re
si
du
es
 in
vo
lv
in
g 
is
op
re
ny
la
tio
n)
 
N
or
m
al
/d
el
ay
 
fe
m
al
e,
 1
6 
H
un
ga
ry
,  
si
st
er
 w
ith
 #
30
3-
30
4 
(C
ar
r a
nd
 G
ou
ra
s 
19
65
; Y
am
am
ot
o,
 
Si
pp
el
 e
t a
l. 
19
97
; 
K
ha
ni
, N
ie
ls
en
 e
t a
l. 
19
98
) 
#3
03
-3
03
 (C
as
e 
1:
 
N
IH
#0
5-
49
-4
2)
 
Ex
on
 5
 d
el
et
io
n 
Fr
am
es
hi
ft 
m
ut
at
io
n:
 
pr
em
at
ur
e 
st
op
 c
od
on
 
N
or
m
al
/d
el
ay
 
fe
m
al
e,
 3
6 
Je
w
is
h 
an
ce
st
or
 
H
un
ga
ry
/U
kr
ai
ne
 
(C
ar
r a
nd
 G
ou
ra
s 
19
65
; Y
am
am
ot
o,
 
Si
pp
el
 e
t a
l. 
19
97
) 
#3
03
-3
04
 
V
38
0D
,  
Se
r5
36
(4
bp
-d
el
) 
C
om
po
un
d 
he
te
ro
zy
go
us
 
(n
eg
at
iv
e 
ch
ar
ge
 in
 
ca
ta
ly
tic
 d
om
ai
n/
lo
ss
 o
f 
la
st
 2
2 
re
si
du
es
 in
vo
lv
in
g 
is
op
re
ny
la
tio
n)
 
N
or
m
al
/d
el
ay
 
fe
m
al
e,
 1
3 
H
un
ga
ry
,  
si
st
er
 w
ith
 #
30
3-
30
2 
(C
ar
r a
nd
 G
ou
ra
s 
19
65
; Y
am
am
ot
o,
 
Si
pp
el
 e
t a
l. 
19
97
; 
K
ha
ni
, N
ie
ls
en
 e
t a
l. 
19
98
) 
Ex
on
 5
 d
el
et
io
n 
Fr
am
es
hi
ft 
m
ut
at
io
n:
 
pr
em
at
ur
e 
st
op
 c
od
on
 
N
or
m
al
/d
el
ay
 
m
al
e,
 6
 
A
sh
ke
na
zi
 Je
w
is
h 
(C
id
ec
iy
an
, Z
ha
o 
et
 
al
. 1
99
8)
 
Fa
m
ily
 6
10
29
 (#
11
) 
c.
82
7+
62
3_
88
3d
el
 
Pa
rti
al
 E
xo
n 
3 
de
le
tio
n 
(1
.1
 k
b)
 
N
or
m
al
/d
el
ay
 
m
al
e,
 1
9 
Pa
ki
st
an
 
(Z
ha
ng
, Z
ul
fiq
ar
 e
t a
l. 
20
05
) 
Fa
m
ily
 6
10
29
 (#
13
) 
c.
82
7+
62
3_
88
3d
el
 
Pa
rti
al
 E
xo
n 
3 
de
le
tio
n 
(1
.1
 k
b)
 
N
or
m
al
/d
el
ay
 
fe
m
al
e,
 1
6 
Pa
ki
st
an
 
Fa
m
ily
 6
10
29
 (#
15
) 
c.
82
7+
62
3_
88
3d
el
 
Pa
rti
al
 E
xo
n 
3 
de
le
tio
n 
(1
.1
 k
b)
 
N
or
m
al
/d
el
ay
 
fe
m
al
e,
 1
3 
Pa
ki
st
an
 
JU
#0
00
8 
(I
II
-2
) 
P3
91
H
 
M
ut
at
io
n 
in
 c
at
al
yt
ic
 
do
m
ai
n 
R
ed
uc
ed
/d
el
ay
 
m
al
e,
 3
5 
Ja
pa
ne
se
 
(H
ay
as
hi
, G
ek
ka
 e
t a
l. 
20
07
) 
JU
#0
00
8 
(I
II
-3
) 
P3
91
H
 
M
ut
at
io
n 
in
 c
at
al
yt
ic
 
do
m
ai
n 
R
ed
uc
ed
/d
el
ay
 
fe
m
al
e,
 3
1 
Ja
pa
ne
se
 
Fa
m
ily
 R
P1
9 
c.
61
4C
>A
; p
.S
20
5X
 
N
on
se
ns
e 
m
ut
at
io
n:
 
pr
em
at
ur
e 
st
op
 c
od
on
 
N
or
m
al
/d
el
ay
 
8 
af
fe
ct
ed
 
in
di
vi
du
al
s, 
ag
e 
3-
66
 
Pa
ki
st
an
 
(A
za
m
, C
ol
lin
 e
t a
l. 
20
09
) 
Ya
m
am
ot
o,
 N
ob
ou
sk
i 
U
nk
no
w
n 
U
nk
no
w
n 
(s
ho
rte
r O
S)
 
N
or
m
al
/d
el
ay
 
m
al
e,
 3
1 
Ja
pa
ne
se
 
(H
as
hi
m
ot
o 
an
d 
K
is
hi
 
20
09
) 
89
	  
in these cones affecting both GRK1 and GRK7 (Hayashi, Gekka et al. 2007). The possibility that 
the photoreceptors with P391H mutation suffer some degree of degeneration leading to the cone 
defect remains, as shown in GRK1-/- mouse photoreceptors. The clinical presentation of Oguchi 
patients seems indistinguishable across the different mutations, although the molecular 
consequences of these mutations to GRK1 may be quite different.  
Structure/Function of GRK1 
 Crystal structures of modified and inactive GRK1 have been solved to provide some 
knowledge about the structure-function relationship of the kinase. Furthermore, one of the 
signaling molecules that modulate GRK1 function in photoreceptor is recoverin (Chen 2002; 
Komolov, Senin et al. 2009). Recoverin interacts with GRK1 in a Ca2+-dependent manner (Chen, 
Inglese et al. 1995), which will be discussed in the following section. Recent studies have 
revealed the molecular interaction between recoverin and GRK1. In Ames et al., the NMR 
structure of the first 25 amino acid of GRK1 (RK25) complex with Ca+2-bound recoverin is 
solved. Residues 4-16 of RK25 form an amphipathic α-helix, where the hydrophobic surface 
interacts with a conserved groove lined with hydrophobic residues in recoverin. This N-terminal 
groove of recoverin, comprised of nine hydrophobic residues conserved across other neuronal 
calcium sensors, is implicated in target recognition (Ames, Levay et al. 2006). This N-terminal 
groove is exposed through the Ca2+-myristoyl switch to allow recoverin binding to GRK1. The 
residues in GRK1 responsible for binding recoverin are V9, V10, A11, A14, and F15, which 
form a network of hydrophobic interactions to confer a Kd of 1.4 µM with recoverin. Mutations 
of these hydrophobic residues abolish GRK1 binding to recoverin (Ames, Levay et al. 2006). In 
addition, the N-terminal residues of GRK1 are required for rhodopsin binding (Higgins, Oprian 
et al. 2006). Taken together, the binding of recoverin to GRK1 at the N-terminal domain 
prevents GRK1 from association to rhodopsin when Ca2+ level is high. As the calcium level 
drops in photoreceptors upon illumination, myristoyl-group on recoverin is sequestered within 
the hydrophobic groove, resulting in dissociation of recoverin from GRK1 and allowing GRK1-
rhodopsin interaction.  
 While GRK1 is responsible for the phosphorylation of R*, the molecular interaction 
between kinase and the GPCR remains unclear. In the GRK family, the structures of GRK2 and 
GRK6 are solved (Boguth, Singh et al. ; Lodowski, Pitcher et al. 2003; Lodowski, Tesmer et al. 
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2006). Recently, six GRK1 crystal structures are reported in various distinct conformations to 
demonstrate the key elements important for kinase activity and interaction with R* (Singh, Wang 
et al. 2008). The GRK1 in the study does not have the last 13 residues (GRK1535), which 
include the isoprenylation site. In these structures, the GRK1 kinase domain is similar to a 
typical Ser/Thr kinase (AGC Kinase), which contains a large (residues 181-268) and small 
(residues 269-454) kinase lobe and a C-terminal kinase extension. The active site is formed 
within a cleft between the large and small kinase lobe and complex with two Mg2+ and the 
nucleotide, ATP or ADP. At the active site, the surface of the large lobe is lined with basic 
residues to bind with rhodopsin’s C-terminal peptides. The small lobe contains the phosphate-
binding loop (P-loop) to interact with the triphosphate of ATP. However, the P-loop (Gly-rich 
B1-B2 turn) in GRK1 is observed to shift away from the nucleotide-binding site when compared 
to GRK2 and GRK6. In fact, GRK1’s P-loop resembles more closely to the structure in Protein 
Kinase A without any bound nucleotide (Apo-PKA). In the apo-GRK1 structure, the kinase 
domain adopts a more flexible conformation as compared to nucleotide-bound GRK1. It is 
hypothesized that the kinase domain adopts a rigid conformation upon nucleotide binding and 
become fully closed and active upon binding to R* at the second and third cytoplasmic loops.  
 Residues 455-511 forms the C-terminal Kinase Extension domain in GRK1 and contains 
three regions: the C-terminal (large) lobe tether (residues 455-471), an active site tether (AST, 
residues 472-480), and an N-terminal (small) lobe tether (residues 498-511). The N-terminal and 
C-terminal lobe tethers have been previously described, while AST has not, due to its sequence 
variability among GRKs and AGC kinases. GRK1’s AST can only be observed in the 
nucleotide-bound structure and becomes disorder in the apo-kinase, similar to the one in PKA. 
GRK1 AST includes the “tail loop” (Asp472-Tyr477), which packs closely to the active site, and 
is predicted to participate in substrate stabilization. The AST is connected to the N-terminal lobe 
tether through residues 481-489, which contains the autophosphorylation sites (Ser488/Thr489). 
The phosphorylation status of the two residues is unclear in the structure, although they are 
phosphorylated in mass spectrometric analysis in the presence of ATP (Palczewski, Buczylko et 
al. 1992; Singh, Wang et al. 2008). It is speculated that the autophosphorylation may participate 
in electrostatic interaction with Arg222 and Lys221 to stabilize the kinase domain.  
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 The N-terminal structure of GRK1535 is visible in one of the six crystals (form I, PDB 
3C4W). The N-terminus (up to residue 32) forms extensive contacts with the RH domain and 
some with the kinase domain. Two novel phosphorylation sites at Ser5 and Thr8 are identified, 
but only Ser5 is phosphorylated in native bovine GRK1. Whether phosphorylation of these sites 
affects GRK1 activity during phototransduction remains to be determined. Interestingly, the N-
terminal structure determined by crystallography is different from the RK25 amphipathic helix 
determined by NMR that complex with Ca2+-recoverin. Recently, a more ordered GRK6 
structure revealed the N-terminal region as a helix that interacted with the C-terminal Kinase 
Extension (C-tail) to stabilize the large and small kinase lobe and adopt a near active 
conformation (Boguth, Singh et al.). A set of residues from the small lobe (Arg190), N-terminal 
helix (Ala8, Asn9, Leu12, and Leu13), and C-tail (Ile472 and Lys475) forms a network of 
hydrophobic interactions and hydrogen bonds to stabilize the kinase. As these residues are highly 
conserved in GRK1, it is likely a similar intramolecular network is required for GRK1 to become 
activated.  It is also possible that the amphipathic helix formation of GRK1 requires the presence 
of recoverin, the GPCR, or other cofactors. Further study is required to resolve the structure and 
interaction of N-terminus with other regions during GRK1 activation. 
 The RH domain of GRK1 is made up of nine α-helices that are typical of the RGS 
domain, with two additional GRK-specific helices. More importantly, GRK1 are observed in 
crystals to dimerize at a hydrophobic surface in the RH domain. The dimer interacting residues 
are conserved in all GRKs except GRK2 and GRK3. However, GRK1 runs as a monomer on size 
exclusion chromatography and analytical ultracentrifugation. In addition, mutations (D164A, 
L166K) in the binding interface do not affect the biochemical properties of GRK1. These results 
suggest that dimer formation in the crystal structure may just be a beautiful artifact of high 
GRK1 concentration. In light of this, a few caveats have to be taken in account with the 
structures of the truncated GRK1 (GRK1535). The affinity (Km) and activity (Vmax) of GRK1535 
deviates from the full-length GRK1, which suggests the kinase domain in GRK1535 does not 
reflect the native conformation. Furthermore, the structure of the N-terminal domain in 
GRK1535 is different from the RK25 bound to Ca2+-recoverin (Ames, Levay et al. 2006; Singh, 
Wang et al. 2008). It is possible that the N-terminal helix formation is induced through the 
interaction with Ca2+-recoverin and needs further investigation. To resolve these discrepancies, 
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crystal structure of the full-length and active GRK1 is needed to fully understand the 
intermolecular and intramolecular interactions between GRK1, recoverin, and rhodopsin. 
Regulations of GRK1 activity 
 Several signaling molecules have been identified to regulate GRK1 function in 
photoreceptors. As demonstrated through biochemical and structural analysis, recoverin interacts 
with GRK1 and negatively regulates GRK1 in a light-dependent manner as the calcium 
concentration changes (Chen 2002; Komolov, Senin et al. 2009). In the dark, high level of cGMP 
opens the CNG channel on the plasma membrane and maintains a high Ca2+ concentration in the 
OS. The high Ca2+ level induces exposure of the myristoyl group of recoverin and allows it to 
translocate to OS. At the disk membrane, recoverin inhibits GRK1 activity through interactions 
of the N-terminal domains. As light stimulation leads to a drop in calcium concentration, the 
myristoyl group of recoverin becomes embedded within the protein and recoverin loses its ability 
to associate with the membrane and perhaps diffuses out of OS (Strissel, Lishko et al. 2005). 
Without calcium, the inhibition of GRK1 is relieved to allow R* phosphorylation. While studies 
have shown that recoverin myristoylation is not required for its inhibition on GRK1, it does 
enhance the cooperative effect of recoverin on GRK1 (Chen, Inglese et al. 1995). In mouse 
photoreceptors lacking recoverin, the recovery is faster compared to wild-type rods (Makino, 
Dodd et al. 2004). In contrast, addition of exogenous recoverin prolongs photoresponses through 
enhanced inhibition of GRK1 and increased R* lifetime (Gray-Keller, Polans et al. 1993; 
Erickson, Lagnado et al. 1998). However, there was one study in which titrating the calcium 
concentration in the OS does not affect R* phosphorylation (Otto-Bruc, Fariss et al. 1998). This 
argues against a role of recoverin in modulating R* lifetime through GRK1. To further test 
whether recoverin influences R* lifetime through regulating GRK1, Chen et al. underexpressed 
GRK1 to make rhodopsin deactivation the slowest step in rod recovery. Under such condition, 
the presence of background light accelerates rod recovery but this effect disappears when 
recoverin is removed from photoreceptors. In the absence of recoverin, the inhibitory control on 
GRK1 is removed and rhodopsin phosphorylation occurs faster (Chen, Woodruff et al. 2010). 
Thus recoverin is indeed a negative regulator of GRK1 in photoreceptors.   
 In addition to recoverin regulation, PKA has also been found to phosphorylate and 
negatively regulate GRK1 (Horner, Osawa et al. 2005). In vitro, GRK1 is phosphorylated at 
93
Fi
gu
re
 3
.1
. C
ur
re
nt
 u
nd
er
st
an
di
ng
 o
f G
R
K
1 
fu
nc
tio
n 
in
 p
ho
to
re
ce
pt
or
s. 
In
 th
e 
da
rk
, t
he
re
 is
 a
 h
ig
h 
C
a2
+  a
nd
 c
G
M
P 
co
nc
en
tra
tio
n 
in
 th
e 
O
S.
 H
ig
h 
C
a2
+  i
s d
et
ec
te
d 
by
 
an
d 
bo
un
d 
to
 th
e 
C
a2
+ -
bi
nd
in
g 
pr
ot
ei
n,
 re
co
ve
rin
 (R
ec
). 
C
a2
+  b
in
di
ng
 in
du
ce
s t
he
 
ex
po
su
re
 o
f t
he
 m
yr
is
to
yl
at
ed
 g
ro
up
 o
f R
ec
 to
 a
llo
w
 m
em
br
an
e 
as
so
ci
at
io
n 
on
 th
e 
di
sk
 
m
em
br
an
e.
 M
em
br
an
e-
bo
un
d 
R
ec
 th
en
 b
in
d 
to
 th
e 
N
-te
rm
in
us
 o
f G
R
K
1 
to
 in
hi
bi
t i
ts
 
ac
tiv
ity
 to
w
ar
ds
 rh
od
op
si
n,
 th
e 
he
pt
ah
el
ic
al
 G
PC
R
. A
t t
he
 sa
m
e 
tim
e,
 G
R
K
1 
is
 
ph
os
ph
or
yl
at
ed
 a
nd
 in
hi
bi
te
d 
by
 P
ro
te
in
 K
in
as
e A
 (P
K
A
, n
ot
 sh
ow
n)
 o
n 
Se
r1
8  a
s P
K
A
 
is
 a
ct
iv
at
ed
 b
y 
hi
gh
 c
A
M
P 
le
ve
l. 
A
fte
r l
ig
ht
 st
im
ul
at
io
n,
 1
1-
ci
s-
re
tin
al
 is
 
ph
ot
oi
so
m
er
iz
ed
 to
 a
ll-
tr
an
s-
re
tin
al
 a
nd
 le
ad
s t
o 
rh
od
op
si
n 
ac
tiv
at
io
n 
(R
*)
. R
* 
an
d 
do
w
ns
tre
am
 si
gn
al
in
g 
ev
en
ts
 le
ad
 to
 c
ha
nn
el
 c
lo
su
re
 a
nd
 d
ec
re
as
e 
in
 C
a2
+  a
nd
 c
G
M
P 
(c
A
M
P)
 le
ve
l. 
Th
e 
dr
op
 in
 c
A
M
P 
pr
ev
en
t P
K
A
-d
ep
en
de
nt
 in
hi
bi
tio
n 
on
 G
R
K
1.
 In
 
ad
di
tio
n,
 d
ro
p 
in
 C
a2
+  l
ea
ds
 to
 th
e 
se
qu
es
te
r o
f t
he
 m
yr
is
to
yl
at
ed
 g
ro
up
 in
 R
ec
. N
on
-
m
yr
is
to
yl
at
ed
 R
ec
 re
le
as
es
 G
R
K
1,
 a
llo
w
in
g 
th
e 
ki
na
se
 to
 p
ho
sp
ho
ry
la
te
 th
e 
C
-
te
rm
in
al
 re
si
du
es
 o
n 
R
*.
 G
R
K
1 
is
 is
op
re
ny
la
te
d 
on
 C
ys
55
8  r
es
id
ue
 fo
r i
ts
 m
em
br
an
e 
lo
ca
liz
at
io
n.
 
94
Fi
gu
re
 3
.1
 
95
	  
Ser21 when incubated with the catalytic subunit of PKA or PKA-holoenzyme stimulated with 
cAMP. Furthermore, urea-stripped ROS incubated with GRK1 and PKA has a 50% decrease in 
rhodopsin phosphorylation. The importance of Ser21 phosphorylation is seen with the phospho-
mimetic mutation (S21E) of GRK1, which has decreased activity towards rhodopsin. In contrast, 
S21A GRK1 is resistant to PKA inhibition and constitutively phosphorylates rhodopsin. These 
evidences suggest a role of PKA in phosphorylating and regulating GRK1 activity in 
photoreceptor. Under high Ca2+ influx in the dark, calmodulin is activated and stimulates cAMP 
synthesis in photoreceptor. High cAMP level activates PKA to stimulate its phosphorylation on 
GRK1 at Ser21. Since the N-terminal residues of GRK1 are important in rhodopsin interaction, 
the phosphorylation at Ser21 introduces a charge residue and obstructs receptor-kinase 
recognition. Future studies are required to test PKA’s action on GRK1 activity in-vivo and its 
modulation on phototransduction. 
 One of the post-translational modifications on GRK1 is isoprenylation, which is the 
covalent attachment of an isoprenoid group to a C-terminal cysteine residue. The modification 
allows the protein to associate with and function at the membrane. Isoprenylation occurs at the 
CaaX box motif (C, cysteine; a, any aliphatic residue; X, the residue that determines the type of 
isoprenoid group attached) (McTaggart 2006). The very C-terminus of GRK1 contains a CaaX 
box motif (C558VLS) to promote isoprenylation (Inglese, Glickman et al. 1992). The last three 
residues are proteolytically removed and a farnesyl group (15 carbon unit) is covalently linked to 
cysteine through a thioester bond. A methyl group is then added to complete the reaction. In 
COS7 cells, GRK1 isoprenylation is abolished by the C558S mutation, and the protein loses its 
ability to associate with the plasma membrane. In addition, GRK1 without isoprenylation has 
reduced (~25%) R* phosphorylation activity, indicating that GRK1 isoprenylation is needed for 
full activity by anchoring the kinase to the disk membrane. It is unclear whether GRK1 
isoprenylation and membrane association affects intrinsic kinase activity, which can be examined 
by measuring the degree of autophosphorylation of the C558S GRK1 mutant. By changing the 
terminal serine to leucine at position 561 (Ser561Leu), the farnesylation of GRK1 can be 
changed to geranylgeranylation (20 carbon unit). When incubating geranylgeranylated GRK1 
with urea-stripped ROS extract, the kinase is found to constitutively anchor to the disk 
membrane independent of light condition, whereas farnesylated GRK1 only localizes to 
membrane in the presence of light. Activated rhodopsin may serve as a docking site for 
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farnesylated GRK1 to associate to the disk membrane, whereas geranylgeranylated GRK1 is 
self-sufficient to anchor to the membrane.  
Similar to other kinases, GRK1 is found to be autophosphorylated at two residues, Ser488 
and Thr489, at the C-terminus. Over the years, experiments studying GRK1 have used the 
autophosphorylation status as a method to assess the intrinsic kinase activity and compare it to 
the kinase’s capability to phosphorylate R* (Horner, Osawa et al. 2005; Higgins, Oprian et al. 
2006). These sites were identified on purified GRK1 from bovine retina through peptide 
digestion and mass-spectrometric analysis (Palczewski, Buczylko et al. 1992). Alanine or 
aspartate substitution at either one of the residues does not affect the phosphorylation of the other 
residue, suggesting that there is no hierarchy between the autophosphorylation reactions 
(Palczewski, Ohguro et al. 1995). The alanine mutants of GRK1 have less affinity for ATP, 
while phospho-mimetic mutants have similar affinity for ATP as regular GRK1. These evidences 
suggest that the phosphorylation at Ser488/Thr489 may affect the conformation of the catalytic 
pocket during phosphorylation. To test the effect of autophosphorylation on GRK1, a synthetic 
peptide that corresponds to the autophosphorylation region is incubated with purified GRK1. The 
peptide did not affect GRK1’s ability to phosphorylate rhodopsin as the kinase has low activity 
towards the peptide. These evidences suggest that the autophosphorylation domain in GRK1 
does not serve as an auto-inhibitory domain, which makes GRK1 unique among the protein 
kinases. Unphosphorylated GRK1 (Ser488 and Thr489 to alanines) have been shown to 
preferentially phosphorylated Ser338 on R*, whereas regular GRK1 phosphorylates Ser338 and 
Ser343. It is speculated that autophosphorylation influences the affinity and enhances the 
dissociation of GRK1 from phosphorylated rhodopsin to allow arrestin binding (Buczylko, 
Gutmann et al. 1991), but its exact physiological role remains to be elucidated.  
It is evident that GRK1 is the kinase responsible for light-dependent rhodopsin 
phosphorylation and the timely R* deactivation in photoreceptor recovery. The regulation of 
GRK1 activity through post-translational modifications and other signaling molecules (PKA and 
recoverin) are important. However, the molecular mechanisms of GRK1 activity on 
photoreceptor function have not been studied in detail. In this part of thesis, I planned on 
investigating the effects of GRK1 post-translational modifications (isoprenylation and 
autophosphorylation) on photoreceptor recovery. More importantly, several GRK1 mutations 
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have been implicated in the pathogenicity of Oguchi Disease. However, their effects on GRK1 
function have not been clearly elucidated and are also studied here. Several mutations, P388H, 
K216R, C558S, V380D, and STAA, are generated (Table 3.2) and studied in cultured cell lines 
and in the rods of transgenic mice. In animals with transgenic expression of mutant GRK1 in rod 
photoreceptors, I hope to determine the mechanisms on how P388H and V380D mutations cause 
the night-blindness phenotype in Oguchi Disease. Also, it has been suggested that the presence 
of GRK7 in human cones preserves the day vision in Oguchi patients. Therefore, as mouse does 
not contain a GRK7 gene, human GRK7 is transgenically expressed to confirm its functionality 
and to generate a mouse model of Oguchi Disease. Through these studies, the role of PTMs and 
Oguchi mutations on GRK1 function and photoreceptor function can be elucidated and further 
our understanding on the structure-function relationship of GRKs. 
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Methods 
Antibody 
To study the kinase activity of GRK1, previous works have used radioisotope labeling to 
measure the chemical reactions mediated by GRK1 autophosphorylation and rhodopsin 
phosphorylation on purified OS. To circumvent from using radioisotope, the polyclonal peptide 
antibodies, A4102 and A4101NP, were raised in rabbit against the peptide sequence, 
CQDVGAFS488T489VKGVAF, which corresponds to GRK1 autophosphorylation site. A4102 
was raised against the phosphorylated peptide at Ser and Thr, whereas A4102 was raised against 
the non-phospho peptide. The peptide was conjugated to keyhole lamprey hemocyanin prior to 
immunization. (Yenzym Antibodies, Burlingame, CA). A4102 is purified from rabbit serum first 
through the nonphospho-peptide conjugated to Sulfo-link agarose beads (Pierce, Rockford, IL), 
then through the phospho-peptide column to ensure the antibody is only specific to the 
phosphorylated-GRK1. A4101NP is the antibody eluted from the non-phospho-peptide column. 
Both antibodies are specific to GRK1 on Western Blot and IHC using in-vitro and in-vivo 
methods. Furthermore, A4102 recognizes specifically phosphorylated S488 and T489, as no 
band is detected on Western blot in the single and double mutants (S488A, T489A, and STAA). 
It has been shown that GRK1 can autophosphorylated the non-mutated residue in the single 
autophosphorylation mutant. With the development of the A4102 antibody, this is the first time a 
phospho-antibody is raised toward autophosphorylated GRK1. 
To study GRK7, the polyclonal peptide antibody Y722NP was raised in rabbit against the 
peptide sequence, CAEIDDFSEVRGVE, which corresponds to GRK7 autophosphorylation site. 
The peptide was conjugated to keyhole lamprey hemocyanin prior to immunization. (Yenzym 
Antibodies, Burlingame, CA). The antibody was affinity purified against the column conjugated 
to the corresponding peptide and stored at -20°C. Total of 6 mL of Y722NP antibody was 
purified at a concentration of 1.08 mg/mL. The specificity of Y722NP to GRK7 was confirmed 
with Western blot on rods expressing GRK7 (GRK723). 
Mutagenesis and cloning 
 Mutagenesis of bovine GRK1 in pBluescript is performed with Stratagene Quikchange 
Kit (Stratagene, Santa Clara, CA) according to manufacture’s instructions. The primers used for 
generating the GRK1 mutations are listed in Table 3.2. Mutations are confirmed by sequencing 
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with VCU Molecular Biology Core Facility. GRK1 mutants are subcloned into pcDNA(GFP) 
plasmid and pFASTBac1 with SalI/NotI for expression studies in HEK293, COS7 and High Five 
Insect cells. To express the GRK1 mutants in mouse rod photoreceptors, GRK1 harboring the 
mutations are subcloned into pRho4.4 with SalI and BamH1, which contain the 4kbp rhodopsin 
promoter and the protamine polyadenylation (pA) signal. The GRK1 mutants are placed 
downstream to the rhodopsin promoter and before the pA signal. The transgenic construct is 
released from the pBluescript backbone with BssHII. The digested DNA is sent to VCU L.T. 
Christian III Transgenic Mouse Core Facility for nuclear injection.  
Ectopic expression of GRK mutants in cultured eukaryotic cells 
 HEK293 and COS7 cells are cultured in a similar condition. Cells are cultured in DMEM 
supplemented with 10% fetal bovine serum (FBS), 20 mM L-glutamine, 1 mM sodium pyruvate, 
and 100 units/mg Penicillin/Streptomycin. High Five (Hi5) insect cells are cultured in Sf-900 II 
SFM media supplemented with 10% FBS. All expression studies are performed in 6 well plates. 
Transfection of pcDNA(GFP) with GRK1 mutations is performed with Lipofectamine 2000 
(Invitrogen, Carlsbad, CA) and harvested 24 hours later for analysis. For proteasome inhibition, 
transfected cells are treated with 100 µM Mg132 in DMSO and harvested 24 hours later.  
Mouse husbandry 
Animal studies were performed under protocols approved by the Virginia 
Commonwealth University IACUC. Integration of the GRK1 mutant transgene is genotyped with 
PCR with the primers, RH1.1, 5’-TCA GTG CCT GGA GTT GCG CTG TGG, and RK-b1, 5’- 
TCG TCG GCC GTG TCG TAG TCC TCG, to produce a 450 base pair product. The 
transmission and expression rates of the transgenic lines are summarized in Table 3.2. The 
amplification conditions for detecting the transgene are: 94°C for 5 minutes, then 35 cycles of 
94°C for 1 minute, 64°C for 1 minute, and 72°C for 1 minutes and followed with a final 
extension of 72°C for 5 minutes. Animals are reared in 12hr cyclic dark/light cycles.  
RNA extraction and reverse-transcriptase PCR (RT-PCR) 
 RNA is extracted in Trizol reagent (Invitrogen, Carlsbad, CA) following manufacture 
procedures. RT-PCR on purified RNA is performed with Superscript III system (Invitrogen, 
Carlsbad, CA) following manufacture’s instructions. Detection of transgene cDNA is performed 
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with RH1.1 and RKB1 primers (bRK) for the 5’-end and Prm1B and bRK-CDGLRTH primers 
(bRKnew) for 3’-end of the transgene. GNAT1-WT Primers (Table 2.1) is used to control for 
DNA contamination as the primer set covers a small intron. Expresser is confirmed with the 
presence of PCR product in the 5’-end and 3’-end transgene.  
Western Blot 
 Mice were euthanized with CO2, followed with cervical dislocation. Eyeballs were 
removed with forceps and placed in 1X PBS for extraction. The cornea and lens were removed 
before separating the retina from the retinal-pigmented epithelium (RPE). For one retina, it is 
homogenized in 75 µL 1X PBS and solubilized in 75 µL LSB Buffer, followed with incubation 
at 95°C for 10 minutes. Retinal proteins were resolved on a 12% Tris-HCl polyacrylamide gel 
and electrophoresed in 1X SDS-Page buffer at 150V for 100 minutes. Following SDS-Page, the 
proteins were transferred onto nitrocellulose membrane in 1X transfer buffer at 250 mA for 120 
minutes. The membrane was stained with Ponseau S (0.1% w/v Ponseau S in 5% glacial acetic 
acid) to ensure the completion of transfer. Ponseau S was washed away with distilled H2O. For 
immuno detection, the membrane was blocked in blocking buffer (10% milk in 1X TBST) for 1 
hour at room temperature (RT). Primary antibody was diluted in blocking buffer and incubated 
with the membrane for 2 hours at RT. After primary antibody incubation, the membrane was 
washed four times in 1X TBST at 5 minutes each. The animal-specific secondary antibody was 
diluted (1:30k) in blocking buffer and incubated with the membrane for 1 hour at RT. Following 
secondary antibody, the membrane was washed six times in 1X TBST at 10 minutes each before 
developing it using the SuperSignal West Dura Chemiluminescent Substrate (Thermo Scientific, 
Rockford, IL). Blot image was captured on film and on the Kodak IS440 CF machine.  
Immunohistochemistry 
 A small burn mark was placed on the superior side on the mouse cornea before the eyes 
were dissected in 1X PBS (Phosphate-buffer saline, pH 7.4). A small incision was made on the 
cornea near the ora serrata to allow fluid permeation. The eyeball was fixed overnight in 4% 
paraformaldehyde in 1X PBS at 4°C. After fixation, the cornea and the lens were carefully 
removed and the eyecup was cryo-protected in 30% sucrose in 1X PBS at 4°C. After the eyecup 
settled in the sucrose solution, it was embedded and frozen in TBS (Triangles Biomedical 
Sciences, Durham, NC, USA) at -80°C. Frozen eyecup blocks were sectioned at 24µm. For 
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immunostaining, sections were washed three times with 1X PBS at five minutes each. Washed 
sections were blocked with 10% goat serum in PBT (0.3% Triton X-100 in 1X PBS) for 1 hour 
at room temperature (RT). Blocking solution was removed before adding the primary antibody. 
Primary antibody was diluted with 10% goat serum in PBT, applied over the section, and 
incubated overnight at RT. After incubation, sections were washed three times with PBT at five 
minutes each. After washing, secondary antibody was diluted with 10% goat serum in PBT, 
added to the sections and incubated for two hours at RT. After incubation, sections were washed 
three times with PBT at ten minutes each. DAPI was used for nuclear staining at a final 
concentration of 500 ng/mL and applied during the secondary incubation. Finally, sections were 
protected with ProLong Gold antifade reagent (Invitrogen, California), mounted with cover slips 
and sealed with nail polish. Confocal images were taken with Zeiss META LSM 510 confocal 
microscope in the VCU Microscopy Core Facility.  
Electroretinogram (ERG) 
 ERG is recorded with the LKC UTAS-3000 System (LKC Technologies, Gaithersburg, 
MD). All procedures are performed in the dark with night-vision goggle. Dark-adapted mouse is 
anesthetized with ketamine/xylazine mixture (150/10 mg/kg; intra-peritoneal) and then the eyes 
dilated with tropicamide drops for 10 minutes. After dilation, the animal was placed in the 
ganzfeld with a water-heated plastic coil to maintain the body temperature at 35-37°C. Two 
gold-plated-electrodes are placed in front of the cornea and 1X PBS was applied to allow 
electrical contact. The ground electrode was placed on the forehead of the mice. Background 
light is turned on for 10 minutes to suppress the rods and increase the cone response. After light 
adaptation, a 1.63 log cd s m-2 stimulus was delivered at 1Hz to assess the photopic response of 
the retina. 90 responses were averaged and stored by the EMWin software. Data was exported 
into and analyzed in Microsoft Excel software. Due to the small ERG a-wave amplitude from 
mouse cones, the b wave amplitude derived from the cone responses was quantified across 
different genotypes to compare the functionality of replacing GRK1 with GRK7.  
Statistical analysis 
 All statistics were performed using Sigma Pro 7.0. One-way Anova test or student t-test 
were performed across different groups/genotypes to obtain statistical significance of p value < 
0.05. 
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Retina fractionation 
 Two fresh retinas were extracted as described above (“Western Blot”) from one animal 
and placed together in a 1.5 mL microfuge tube. All procedures were performed on ice until 
solubilization with 2X LSB and heat treatment. The retinal sample was resuspended in 150 µL 
1X PBS and sonicated with (machine) for 1 cycle of 5 pulses. 50 µL of the retinal extract was 
removed, mixed with 50 µL 2X LSB and labeled as total extract (T). The remaining 100 µL 
retinal extract was ultracentrifuged at 100,000 x g for 1 hour at 4°C to separate the soluble and 
membrane contents. The supernatant (S) was carefully removed (~100 µL), placed in a new tube, 
and mixed with 1:1 2X LSB. The pellet (P) fraction was resuspended with 100 µL 1X PBS and 
also mixed with 100 µL 2X LSB. All LSB treated samples were incubated at 95°C for 10 
minutes. 8 µg of each extracted was loaded on 12% SDS-PAGE gel for Western Blot analysis. 
Complete separation of soluble and membrane fractions were determined by RGS9-1 and 
GAPDH localization. RGS9-1 is completely membrane localized, while GAPDH is a cytosolic 
marker.   
Outer Segment (OS) Isolation 
 To determine proteins in outer segment localization, outer segments were isolated from 5 
mice retinas. 6 retinas were isolated from 3 mice, one was used as a total protein control and the 
other 5 retinas were used to purify OS. The 5 retinas were pooled in 500µL 47% sucrose in ROS 
buffer (20 mM MOPS pH 7.4, 60 mM KCl, 30 mM NaCl and 2 mM MgCl2) and vortex at low 
intensities for 2 minutes. The agitation force detached outer segments from the photoreceptor, 
which then partitioned into the 47% sucrose. After vortex, the solution was centrifuged at 10,000 
x g for 30 minutes at 4°C. The supernatant was removed to a new tube and mixed 1:1 with ROS 
buffer, which diluted the sucrose to 23.5%. The pellet was resuspended in another 500 µL 47% 
sucrose in ROS buffer and OS extraction was repeated. The supernatants were pooled and 
centrifuged at 20,000 x g for 30 minutes at 4°C. At 23.5% sucrose, the OS is denser and can be 
pelleted. The pellet containing OS was resuspended in 75 µL ROS buffer and mixed with 75 µL 
2X LSB. 8 µL of ROS extract was resolved on 12% SDS-Page gel to determine the protein 
content. 
Rhodopsin bleaching time course  
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 To determine the amount of rhodopsin bleached when exposed to the background light 
(30 cd•m2) LKC UTAS-3000 System, spectrum analysis was performed on dark-adapted retinas 
exposed to background light at various time points. All procedures were performed in the dark 
with night goggle until exposure to background light in the ganzfeld. Retinas are extracted and 
pooled from 10 dark-adapted C57BL/6 (Jackson Laboratory, Bar Harbor, Maine) mice. During 
extraction, retinas were kept on dry ice until completion. 20 retinas were homogenized in 500 µL 
Buffer A (10% Triton X-100 in 1X PBS). Retinal Extract was quickly centrifuged to pellet 
insoluble content. 25 µL of the extract represented the rhodopsin content from one retina and was 
diluted with Buffer A to the final volume of 500 µL for spectrophotometer reading. To test 
rhodopsin bleaching rate, one retina (500 µL) was exposed to background light for 0, 1, 2, 5, and 
10 minutes. Rhodopsin absorbance is recorded with spectrophotometer at 498 nm (A498) before 
(Apre) and after background exposure (Apost). After completion of the last time point, all samples 
are exposed to a bright-light box for 5 minutes to bleach all the rhodopsin. A498 reading is taken 
again on all samples (Ableached). The percent of rhodopsin bleached at each time point is 
calculated with equation 1, %Rhodop sinbleached = Apost − AbleachedApre − Ableached
. All time points are performed in 
triplicates.  
Time course of dark adaptation 
 To test the recovery of mouse photoreceptor after 50% bleach, animals are dark-adapted 
overnight before performing ERG. Dark-adapted animals are anesthetized with 
ketamine/xylazine (150/10 mg/kg; intra-peritoneal) and their eyes dilated with tropamide drops 
for 10 minutes. Mouse is placed into the ganzfeld in the same procedure in the method ‘ERG’. A 
1.4 log cd S/m2 flash is triggered to obtain the fully dark-adapted response. Afterwards, the 
backlight (30 cd m2) is turn on for two minutes to reach 50% rhodopsin bleach. After turning the 
light off, log 1.4 log cd S/m2 flash is triggered at time 1, 2, 5, 10, 15, 30, 45 and 60 minutes to 
assess the recovery from bleach. The ERG A wave amplitude is used to measure the 
photoreceptor recovery and is normalized to the pre-bleach response.  
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Results 
Characterization of Y722NP, a GRK7-specific peptide antibody  
 During the generation of the MCV7 and MCV8 transgenic lines, the polyclonal Y722NP 
antibody was generated against the synthetic peptide, CAEIDDFSEVRGVE, which corresponds 
to GRK7 autophosphorylation site. Comparing GRK723 (rod-specific GRK7 expression) to 
control retinal extracts, Y722NP is specific to GRK7 on Western Blot (Figure 3.2A). 
Furthermore, the antibody is specific to GRK7 on MCV7 retinal sections with IHC (Figure 3.2B) 
and does not have any non-specific signals, as no immunofluorescence is detected in GRK1-/- 
retina. 
Functional replacement of GRK7 for GRK1 in mouse cones 
 To test whether human GRK7 is functional in mouse cones, MCV7 and MCV8 are 
crossed into GRK1-/- background to generate the MCV7-/-, MCV8-/- and MCV78-/- animals. By 
removing the endogenous GRK1 in cone photoreceptor, the function of GRK7 in MCV7 and 
MCV8 cones can be assessed with photopic ERG. Under light-adapted condition, the cone 
responses from 1Hz flicker flash of 1.63 log cd S/m2 are recorded from WT, MCV7-/-, MCV8-/-, 
MCV78-/- and GRK1-/- animals (Figure 3.3). After quantification of the cone-derived ERG B 
wave amplitude, flicker responses are 196 µV in WT cones, 105 µV in MCV7-/- cones, and 145 
µV in MCV8-/- and MCV78-/- cones. The flicker response is abolished in GRK1-/- cones down to 
18 µV. The expression of GRK7 in cone photoreceptors restored the flicker responses in cones 
lacking GRK1. The flicker response amplitude in MCV7-/- cones is less than the one in MCV8-/- 
cones (Figure 3.3B), which corresponds with the different GRK7 expression pattern between 
MCV7 and MCV8 (Figure 2.10). Interestingly, the responses amplitude in MCV8-/- and MCV78-
/- cones are very similar, confirming that the GRK7 expression in MCV8 is almost in all the 
cones and therefore, additional GRK7 from the MCV7 transgene does not further increase the 
response amplitude. However, the restoration of the cone responses in MCV8-/- and MCV78-/- 
does not reach the WT responses, suggesting that some defects are presented in these transgenic 
cones. 
Generation of GRK1-specific antibodies, A4101NP and A4102.  
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To study GRK1 autophosphorylation at S488 and T489, the phospho-antibody, A4102 and 
A4101NP, were generated. A4102 and A4101NP were raised against a phospho-peptide and the 
non-phospho-peptide corresponding to GRK1 autophosphorylation site (Figure 3.4A). The 
specificity of A4102 antibody is tested with a kinase assay by treating recombinant GRK1 with 
either ATP or Protein-Phosphatase-2A (PP2A). On Western blot, A4102 only detect GRK1 
under the treatment of ATP, which promotes GRK1 autophosphorylation. No phosphorylated 
protein can be detected under treatment of Protein Phosphatase 2A (Figure 3.4B). To further test 
A4102 specificity, retinas from WT and GRK1-/- mice are compared. A4102 does not detect any 
signal in GRK1-/- retina (Figure 3.4C, top panel). Also, an antibody depletion assay is performed 
by incubating the A4102 antibody with agarose beads coupled to the phosphorylated or 
unphosphorylated peptide. After centrifugation, the supernatant above the beads is used as 
primary antibody for Western blot as shown in figure 3.4C. GRK1 detection is lost when A4102 
binds to beads with phosphorylated peptide and is depleted from the supernatant (Figure 3.4C, 
bottom panel). More importantly, A4102 does not recognize the unphosphorylated GRK1, since 
it does not bind to the unphosphorylated peptide and remained in the supernatant to recognize 
GRK1 on immunoblot (Figure 3.4, middle panel). On retinal sections, A4101NP (Figure 3.4E) 
and A4102 (Figure 3.4F) also recognize GRK1 in the OS of photoreceptors, similar to the 
commercial GRK1 antibody, G8 (Figure 3.4). None of the three antibodies (G8, A4102, 
A4101NP) detect any signals in GRK1-/- sections, confirming their specificity to GRK1 on IHC. 
A4101NP antibody recognizes the non-phosphorylated and phosphorylated GRK1, whereas 
A4102 is specific to phosphorylated-GRK1 (pGRK1). A4102 is a useful reagent to monitor 
changes in GRK1 autophosphorylation, which reflects the intrinsic kinase activity. 
The light/dark transition on GRK1 autophosphorylation 
To test whether GRK1 autophosphorylation is modulated by dark and light condition, a dark 
adaptation time course is performed. WT mice are dark-adapted and their retinas extracted at 
times 0, 0.5, 1, 12, 24 and 240 hours. After 240 hours in the dark, one animal was placed into 
ambient light for 1 hour before the retinas were harvested. Comparing autophosphorylated 
GRK1 (A4102) to total GRK1 (G8) (Figure 3.5A), the autophosphorylation decreases by ~50% 
within the first 30 minutes of dark-adaptation (Figure 3.5B, time point 2), which then returns to 
basal level after one hour. The implication of the drop in autophosphorylation requires further 
investigation. It is possible during dark adaption, GRK1 activity increases in order to 
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phosphorylate and deactivate R*. If autophosphorylation has an inhibitory effect on GRK1 
activity, then reducing autophosphorylation (through a protein phosphatase) can increase GRK1 
activity. As GRK1 kinase activity increases, autophosphorylation then returns to normal level 
and provides a negative feedback on GRK1 activity.  
Ectopic expression of GRK1 mutants.  
Six residues, K216, V380, P388, S488, T489, and C558, in GRK1 are selected to study their roles 
in GRK1 function. K216 is the catalytic residue important in the kinase activity. P388 (P391 in 
human) and V380 are residues mutated in the human Oguchi Disease (Table 3.1). S488, T489, and 
C558 are residues involved in the PTMs for GRK1. S488T489 are found to be autophosphorylated, 
whereas C558 is the isoprenylation site for GRK1. Sequence alignments are performed on 
human GRK1 to GRK7 (Figure 3.6) using the ClustalW2 software. The alignment shows that 
K216 and P388 are conserved across all seven GRK members. The V380 is unique to GRK1, 
whereas C558 is conserved in GRK1 and GRK7. The autophosphorylated residues are presented 
across GRK members with some variations. GRK7 has one of the autophosphorylated residue as 
E, which is phosphomimetic to S and T residues. In the GRK2-group, the autophosphorylated 
residues are expanded to DEED, which are all phosphomimetic. These evidences suggest 
autophosphorylation may play a role in GRK regulation and function. 
 To study GRK1 autophosphorylation, the S488 and T489 residues are mutated to alanines to 
generate the STAA mutant. Also, to test the effects of other mutations, GRK1 harboring K216R, 
C558S, P388H, and V380D are generated (Table 3.2). K216R mutation abolishes GRK1 kinase 
activity (Horner, Osawa et al. 2005) and C558S eliminates GRK1 isoprenylation (Inglese, 
Glickman et al. 1992; Inglese, Koch et al. 1992). P391H and V380D are missense mutations 
found in patients with Oguchi Disease (Yamamoto, Sippel et al. 1997; Khani, Nielsen et al. 
1998; Hayashi, Gekka et al. 2007). As mentioned, human GRK1 P391 correspond to P388 in 
bovine GRK1. These five mutants are first studied with ectopic expression in cultured cells. In 
High Five insect cells, GRK1 mutants have robust expression (Figure 3.7A, top panel). However, 
all of the GRK1 mutants are not autophosphorylated, except for C558S mutant (Figure 3.7A, 
middle panel), suggesting that these mutations abolish GRK1 activity. The absence of 
autophosphorylation in the K216R mutant is expected, as the lysine residue is responsible for 
kinase activity. On the other hand, the C558S mutant is autophosphorylated, which indicates that 
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isoprenylation is not required for GRK1 activation. The C558S mutant has a larger molecular 
weight and runs higher than WT GRK1 due to the lack of proteolytic cleavage of the AAX 
residues.   
To further examine GRK1 mutants in mammalian system, the mutations are cloned into 
pcDNA(GFP) plasmid and expressed in COS7 (Figure 3.7B) and HEK293 (Figure 3.7C). GFP is 
used as transfection control. In contrast to the expression profile in Hi5 cells, GRK1 mutants 
K216R, P388H and V380D have ~90% reduction in protein expression compared to WT GRK1 
(Figure 3.7B and C, G8). The reduction in protein expression and kinase activity in GRK1 with 
kinase-dead mutation (K216R) and the Oguchi mutation (V380D) is consistent with previous 
reports (Figure 3.7B, lane 5 and 6; Figure 3.7C, lane 7 and 9) (Khani, Nielsen et al. 1998; 
Horner, Osawa et al. 2005). On the other hand, this is the first observation on the loss-of-protein 
phenotype for the P388H mutation (Figure 3.7B lane 3; Figure 3.7C lane 3). The reduction in 
GRK1 expression caused by P388H and V380D mutations may provide the mechanism for the 
loss of night vision in Oguchi patients. Loss of GRK1 prolongs the lifetime of R* and prevent 
the timely recovery of photoreceptors. Furthermore, abolishing GRK1 kinase activity also 
resulted in loss of protein, suggesting that kinase activity may be required for GRK1 stability and 
autophosphorylation may confer GRK1 stability. Indeed, loss of autophosphorylation results in 
~50% reduction in GRK1 (Figure 3.7C, lane 11; Figure 3.7D). However, autophosphorylation do 
no account for the complete stability of GRK1 and points to a separate mechanism to stabilize 
the kinase. In addition, single autophosphorylation mutants, S488A and T489A, have reduced 
GRK1 expression (Figure 3.7B, lane 8 and 9). The multiple molecular species of WT GRK1 fall 
into a single lower form in STAA, S488A and T489A, suggesting that the larger GRK1 species 
are phosphorylated. The different expression profiles in P388H, V380D, K216R and STAA 
mutants in insect and mammalian cells can be attributed to the differences in the protein 
degradation machinery between the cell types. 
Consistent in all cell types tested, GRK1 without isoprenylation does not have the CAAX 
motif cleaved, resulting in a larger GRK1 protein (Figure 3.7A, B, and C). Also, GRK1 lacking 
isoprenylation is autophosphorylated; however, after intensity analysis, there is a ~50% drop in 
the phosphorylation level (Figure 3.7D). It is conceivable that GRK1 may have lower kinase 
activity before isoprenylation and assume full activity once it is isoprenylated and localized to 
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the membrane. This observation is consistent with the literature that GRK1 activity on purified, 
light-activated ROS requires farnesylation (Inglese, Glickman et al. 1992; Inglese, Koch et al. 
1992).  
The loss of GRK1 protein expression, but not autophosphorylation, can be restored by the 
treatment of the proteasome inhibitor, Mg132, in HEK293 cells.  
The loss of protein seen in P388H, V380D and K216R mutants may be the consequence 
of protein misfolding. Misfolded proteins are tagged with ubiquitin and subsequently degraded 
by proteasome (Ardley 2009). To test whether proteasome machinery is responsible in degrading 
the GRK1 mutants, HEK293 cells expressing WT and mutant GRK1 are treated with the 
proteasome inhibitor, Mg132, at 100 µM. Transfected cells are dosed at every 6th hour for 24 
hours (Figure 3.7C and D). Mg132 treatment does not affect the level of WT GRK1 level (lanes 
1 vs. 2), while the treatment partially restored ~50% of three mutants, P388H (lanes 3 vs. 4), 
V380D (lanes 7 vs. 8), and K216R (lanes 9 vs. 10). However, no change is observed with 
treatment of STAA mutant (lane 11 vs. 12). The lack of rescue in the STAA mutant suggests that 
the proteasome machinery does not mediate the reduction in GRK1 level through the loss of 
autophosphorylation. This observation may also explain why only ~50% of GRK1 can be 
restored with Mg132 treatment in GRK1 containing K216R, V380D, or P388H mutations. 
Although Mg132 inhibited the degradation of GRK1 mutants, it did not restore the 
autophosphorylation. The lack of autophosphorylation indicates that the restored GRK1 protein 
does not have activity.  
Generation and characterization of mutant GRK1 transgenic mouse lines.  
To study the GRK1 mutants in-vivo, the P388H, C558S, K216R, V380D, and STAA 
mutants (Table 3.2) are expressed in mouse rods with the rhodopsin promoter. Since all GRK1 
mutants, except C558S, are expected to have reduction in protein expression, it is difficult to 
determine the protein expression from the transgene due to the presence of endogenous GRK1. 
On the other hand, the lack of transgenic protein expression is usually caused by the integration 
of the transgene into a genetically silenced region. To circumvent the complication of using 
protein expression as confirmation of transgene expression, PCR is performed on the transgene 
cDNA with bRK and bRKnew primer sets, which bind to the 5’end and 3’end of the transgene, 
respectively, to determine transgene expression (Figure 3.8-3.13). GNAT1-WT primers are used 
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to control for DNA contamination as the removal of intron results in smaller PCR fragment for 
GNAT1 cDNA. The transmission rate of the five transgenic lines is summarized in Table 3.2.  
For P388H transgenic line, five founders are generated with four expression lines. Line 2 
has the highest RNA expression (Figure 3.8B), while no GRK1 protein is detected by 
immunoblotting (Figure 3.8A). TGbRK and TGbRK700-/- are used as positive controls. TGbRK 
has WT bovine GRK1 expression in mouse rod, whereas TGbRK700-/- is TGbRK in GRK1-/- 
background. On Western blot, Bovine GRK1 has a larger MW than mouse GRK1, which is seen 
in Figure 3.8A. The presence of RNA expression without protein expression suggests that P388H 
mutation destabilizes GRK1.  
Next, K216R transgenic line generated four founders with only one expresser. Line 4 has 
the highest RNA expression (Figure 3.9). Line 4 is crossed into GRK1-/- for further analysis. For 
V380D transgenic line, ten founders are generated with six transmitters (Figure 3.10). Out of the 
six transmitters, line 1 and line 5 have the highest RNA expression (Figure 3.10B and C). 
Western analysis of V380D line 1 and 5 in WT background do not reveal any higher running 
molecular species (Figure 3.10A). However, the protein expression in V380D line 1 may have a 
slight increase in the genotype positive mice (Figure 3.10A), which suggests some GRK1 
expression from the mutant transgene. Any mutant GRK1 expression can be clearly determined 
by removing the endogenous mouse GRK1. V380D line 1 is crossed into GRK1-/- background 
for analysis and discussed further in the later sections. For STAA transgenic line, ten founders 
are generated with five transmitters. Out of the five, lines 2 and 7 have high RNA expression 
(Figure 3.11C). Similar to the P388H and V380D transgenic lines, no larger molecular species is 
found in STAA lines on Western blot (Figure 3.11A and B). STAA lines 2 and 7 are crossed into 
GRK1-/- background to study the transgene expression. 
Lastly, C558S transgenic line generated four founders and only one expresser. C558S 
expression reveals the presence of the higher molecular species, which confirms the expression 
of the transgene (Figure 3.12A, G8). In addition, C558S mutant is also autophosphorylated 
(Figure 3.12A, A4102), consistent with the observation that GRK1 without isoprenylation is 
catalytically active. Quantitative analysis shows that C558S has two-fold increase in GRK1 
expression over WT (Figure 3.12B, G8/GAPDH), confirming transgenic protein expression. 
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However, the autophosphorylation of C558S mutant is reduced compared to WT (A4102/G8), 
which implies isoprenylation may affect GRK1 kinase activity. 
By removing the endogenous mouse GRK1, the expression of mutant GRK1 expression 
are isolated and further characterized (Figure 3.13). In GRK1-/- background, V380D (Figure 
3.13A), STAA (Figure 3.13B and C), and C558S (Figure 3.13E) have protein expression. V380D 
and C558S are discussed further in later sections. STAA line 5 does not have any expression and 
its mating is discontinued (Figure 3.13A). STAA lines 2 and 7 have protein expression, as 
expected from the RNA expression (Figure 3.13B and C; Figure 3.11). However, STAA line 2 
displayed a mixed expression profile, as few genotype positive STAA animals have no mutant 
expression (Figure 3.13B). Integration of STAA transgene in line 2 must have occurred at two 
separate regions, where one of them is silenced. This line is terminated because it is difficult to 
isolate the pure expresser from the non-expresser. Also, STAA line 7 has mutant expression at 
15% of GRK1+/- rods, which implies ~7.5% of the WT animals (Figure 3.13D). The low 
expression of STAA can be attributed to the low copy number of the transgene or the instability 
of GRK1 due to the loss of autophosphorylation. By comparing the protein to the RNA level in 
the transgene, the relative stability of GRK1 mutant can be compared to WT level. 
Unfortunately, the TGbRK700-/- animal was lost during this study, which prevents the 
comparison of the mutant bovine GRK1 to the WT bovine GRK1. Furthermore, the endogenous 
WT GRK1 RNA level cannot be compared to the transgene RNA level due to their different 
promoters. Mouse GRK1 is under the endogenous GRK1 promoter, whereas the 4kb rhodopsin 
promoter drives transgene GRK1 expression. Under the different promoter, the WT and 
transgene GRK1 DNA transcription are not under the same regulatory elements. Therefore, the 
characterization of P388H and K216R transgenic lines has been discontinued. The higher GRK1 
expression in V380D and C558S animals (Figure 3.13E) facilitates their characterization in 
GRK1-/- background to study their effects on GRK1 functions and rod phototransduction. 
Characterization of V380D line 1 in GRK1-/- background (V380D) 
 The GRK1 mutation, V380D, is first identified in patients suffering from Oguchi Disease 
(Table 3.1). Rod-specific expression of V380D GRK1 is established with the transgenic 
construct in Figure 3.14A. Western analysis is performed in WT, V380D, and GRK1-/- retina to 
ensure no changes in other phototransduction components (GC, PDEα, RGS9-1, Gβ5-L, and 
137
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recoverin) (Figure 3.14B). Note the decrease in GRK1 expression in V380D compared to WT. 
Semi-thin plastic section of WT, V380D, and GRK1-/- demonstrates that V380D expression can 
prevent the photoreceptor degeneration seen in GRK1-/- (Figure 3.14C). The degeneration in 
GRK1-/- retina has reduced nuclear layer, and distorted IS and OS. The restoration of 
photoreceptor morphology in V380D suggests that the mutant GRK1 is functional. 
 Quantitatively, GRK1 expression in V380D is 40% compared to WT level, whereas 
autophosphorylated GRK1 in V380D is 20% when normalized to total GRK1 protein (Figure 
3.15A). Altogether, V380D is calculated to have 8% catalytic active GRK1 compared to WT. 
The reduced autophosphorylation in V380D implies the mutant has defective activity. With IHC 
on retinal cross sections, V380D mutant is mislocalized throughout the photoreceptor (Figure 
3.15B, left panel), whereas the autophosphorylated-GRK1 is only found in the ROS (Figure 
3.15B, right panel). While V380D mutation renders GRK1 partially defective, the residual 
functional kinase can still be properly targeted to the ROS as demonstrated by IHC. To test 
whether V380D can properly deactivate R*, rhodopsin phosphorylation assay is performed with 
the phospho-rhodopsin antibody, α-p334, on mouse section (Figure 3.15C). Like WT, V380D 
mutant can phosphorylate R*, as detected by α-p334 antibody, in a light-dependent manner. 
Furthermore, light-dependent R* phosphorylation is abolished in GRK1-/- animal as expected. 
These evidences confirm that the residual functional V380D GRK1 is properly localized to ROS 
and can function to terminate R* signaling.  
 To further assess the functionality of V380D rods, ERG is performed on dark-adapted 
mouse (Figure 3.16). Overall, no gross differences in the ERG A and B waves are observed 
between WT and V380D animals (Figure 3.16A and B). By analyzing the A wave parameters, 
effective delay (teff), amplification (A) factor, and the A wave amplitude are determined (Figure 
3.16C). The teff is a fitted parameter which indicates the time delay between the flash and the 
negative deflection of the A wave response. The A factor is the measurement of the amplification 
events during the activation phase of phototransduction. WT and V380D have teff of 2.79 and 
1.72 ms, A factor of 424 and 361 s-2, and A wave amplitude of 424 and 361 µV, respectively. 
Only teff shows a statistical difference between WT and V380D. It is not clear how the V380D 
mutation in GRK1 can lead to shorter delay in A wave response and further study is required to 
understand this change in photoreceptor property. B wave analysis determines the implicit time 
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and amplitude, of the responses from bipolar cells (Figure 3.16D). The implicit time, the time 
required for maximum B wave response, is faster in V380D than WT animals at the low and high 
intensities. On the other hand, the B wave amplitude of V380D is reduced at the lower 
intensities. It is unknown how these minor changes in B wave properties arise. It is possible there 
are slight changes in photoreceptor and bipolar cell properties due to the V380D mutation. 
Overall, the ERG responses between V380D and WT animals are similar. 
Characterization of C558S line 2 in GRK1-/- background (C558S) 
 The requirement of isoprenylation for GRK1 membrane association has been established 
in cell culture. However, the regulation of isoprenylation on GRK1 has not been established in-
vivo. Using the rhodopsin promoter, the C558S GRK1 mutant is expressed in mouse rod 
photoreceptor (Figure 3.17A), without affecting the expression of other phototransduction 
proteins. Quantification analysis reveals that C558S GRK1 is expressed at 82% compared to WT 
level; however, the autophosphorylation status of C558S is reduced to 21% when normalized to 
total GRK1 protein (Figure 3.17B). Furthermore, IHC on C558S retinal sections with A4101NP 
and A4102 antibodies shows that the expression of C558S mutant is not homogenous. 
Qualitatively, the expression is in ~60% of the photoreceptors (Figure 3.17C). The expression is 
rod-specific, as the GRK1 signal does not overlap with PNA, a cone-specific marker. 
Furthermore, the GRK1 staining is distributed throughout the photoreceptor in C558S sections 
(Figure 3.17C), suggesting that GRK1 without isoprenylation is mislocalized and cannot be 
targeted to the ROS. 
GRK1 localization in WT, V380D, and C558S retinas 
 To test the effect of the mutations on GRK1 localization, the membrane and cytosolic 
contents are isolated from light-adapted WT, V380D, C558S, and GRK1-/- retinas (Figure 3.18). 
The indication of proper separation between membrane and cytosolic contents is confirmed by 
RGS9-1 and GAPDH. RGS9-1 is a membrane protein, whereas GAPDH is completely soluble. 
In WT retina, GRK1 is mostly membrane-bound (Figure 3.18A). V380D mutant localization is 
evenly distributed between the membrane and cytosolic fractions, indicating a defect in 
membrane association compared to WT GRK1 (Figure 3.18A). In contrast, C558S mutant is 
completely soluble and cannot localize to the membrane, confirming the role of isoprenylation in 
GRK1 membrane association (Figure 3.18B). In addition to membrane fractionation, rod outer 
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segments (ROS) are isolated to determine the proper targeting of GRK1. While the ROS 
purification is not 100%, the isolated ROS from WT retina has a robust amount of GRK1 
expression (Figure 3.18C), along with RGS9-1 expression. On the other hand, a low amount of 
V380D mutant is detected in isolated ROS, corresponding to the autophosphorylated GRK1 
found in the ROS on IHC that can deactivate R*. (Figure 3.15A and B). For C558S mutant, no 
GRK1 is detected from the isolated ROS (Figure 3.18D), further confirming the role of 
isoprenylation in targeting GRK1 to ROS. 
Single rod recording in WT, V380D, C558S, and GRK1-/- animals 
 To assess the function of the transgenic rods in the GRK1 mutant lines, we collaborated 
with Drs. King-Wai Yau and Lihui Cao to record the rod photoresponses using suction pipette 
recordings. Analysis from isolated rod recordings demonstrated similar tpeak and sensitivity (σ) in 
the photoresponses between WT and V380D animals (Figure 3.19). The τrec and τD are 283 and 
221 ms for WT rods, 1060 and 329 ms for V380D rods, and 5800 and 10700 ms for GRK1-/- rods 
(Figure 3.19). The recovery times in dim (τrec) and bright flashes (τD) are larger in V380D 
photoreceptors, due to either a reduction in GRK1 expression and/or a decrease in catalytic 
efficiency. However, the delay in V380D rod is not as severe as GRK1-/-, confirming that V380D 
mutant can phosphorylate R* to recover rod. Interestingly, the recovery of V380D rods is slower 
in dim flashes compared to bright flashes, suggesting that V380D GRK1 activity is dependent on 
the flash intensities.  
 On the other hand, the recovery time constants, τrec and τD, of C558S rods are severely 
prolonged to 5700 and 7900 ms (Figure 3.20A and B), respectively. While C558S mutant 
expression is not homogenous (Figure 3.17C), it is possible that some of the rods recorded do not 
have any mutant GRK1 expression. By recording enough rods in C558S retina, responses from 
rods with and without the mutant protein are obtained. Comparing all the rods recorded, no 
variations in photoreceptor recovery is observed; therefore we conclude that rods with C558S 
mutant expression respond similarly to GRK1-/- rods. The severe recovery delay in C558S rods 
corresponds with the absence of GRK1 in ROS as the lack of isoprenylation prevents GRK1 
membrane association. 
Recovery analysis of V380D and C558S animals 
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 While it is clear that V380D animals can respond to light under scotopic ERG conditions 
and its rods have recovery delays on the single cell resolution, the question remains on how 
V380D mutation in GRK1 causes the night-blinding phenotype in Oguchi Disease. Under 
scotopic condition for ERG, each stimulus only bleaches a small percentage of rhodopsin. 
However, in human Oguchi patients, the delay in dark-adaptation time is observed when the 
subjects transition from light environment into dark condition where a large percentage of R* 
needs to be deactivated and regenerated. To test the ability for the mouse to dark-adapt, the time 
needed for photoreceptors to recovery after exposure to bleaching light is measured (Figure 
3.21). WT animals are dark-adapted overnight and their retinas extracted and exposed to the 
background light in the LKC UTAS-3000 ERG machine for 0, 1, 2, 5, 10 minutes. The free 
rhodopsin contents are measured at 498 nm, the λmax of unbleached rhodopsin, and plotted 
against exposure times (Figure 3.21A). It is determined that 50% of the rhodopsin are bleached 
by two minutes of background light exposure, which is the time used in the subsequent 
experiment for rhodopsin bleaching before dark-adapting the animals (Figure 3.21E). To obtain a 
baseline (pre-bleach), ERG response is recorded from dark-adapted animals with a 1.4 log cd 
S/m2 (10db) flash. Then the background light is turn on for two minutes. After turning off the 
background light, recovery from the 50% bleach is measured with the same 1.4 log cd S/m2 flash 
at various time points. For WT animals, recovery is reached by 10 minutes of dark-adaptation, 
whereas V380D animals recover slower, restoring only 74% of the pre-bleach amplitude at one 
hour of dark-adaptation (Figure 3.21B). This delay in recovery recapitulates the dark-adaptation 
defect in Oguchi patients. In comparison, photoreceptors without GRK1 cannot recovery beyond 
15% of the pre-bleach amplitude, which most likely derives from cones since their recovery is 
faster than rods. For V380D animals, the delay in dark-adaptation is due to the low level of the 
active GRK1. R* phosphorylation becomes limiting as the V380D mutant has only 8% active 
GRK1. To further confirm this hypothesis, recovery time course was recorded from Bark7 and 
95Bark7 animals, which have only 15% GRK1 expression (Chen, Woodruff et al. 2010). The 
recovery in Bark7 and 95Bark7 animals are similarly delayed as observed in V380D animals 
(Figure 3.21C), further suggesting that R* cannot be deactivated in a timely fashion when a high 
concentration of R* and a low amount of active GRK1 are present. As a control, the pre-bleach 
A wave amplitudes are similar in all the animals tested (Figure 3.17D), except for GRK1-/-. The 
reduced A wave response in GRK1-/- animals has been reported and is due to the photoreceptor 
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degeneration caused by the absence of GRK1. The delay in dark-adaptation caused by V380D 
mutation provides a mechanism for the night-blindness in Oguchi patients. 
 Next, the photoreceptor recovery in C558S animals is measured with ERG. Since single 
cell recordings demonstrate that photoreceptors with C558S mutant recover similar to GRK1-/- 
photoreceptors, we tested the ability of C558S animals to recovery from a single bright flash. 
(Figure 3.20C and D). Dark-adapted animals are stimulated with a 1.4 log cd S/m2 flash and 
recovery is assessed at different time point after dark-adaptation. As seen in Figure 3.20D, 
C558S photoreceptor recovery is similar to that of GRK1-/- animals, suggesting that GRK1 
without isoprenylation is unable to terminate R* signaling due to its inability to target to the 
ROS. 
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Discussion 
Oguchi Disease is a type of congenital stationary night blindness (CSNB), characterized 
by a delay in dark-adaptation lasting more than three hours. Mutations in GRK1 and arrestin 
genes have been identified in Oguchi patients. Since GRK1 and arrestin are involved in 
deactivating R*, it is conceivable that defects in R* phosphorylation and arrestin binding result 
in prolonged R* signaling and delayed recovery. The recovery defect is observed in mouse 
photoreceptors lacking GRK1 or arrestin, confirming the pathogenicity of GRK1 and arrestin 
mutations in Oguchi Disease. However, the recovery delay in GRK1-/- rods and cones suggests 
that GRK1-/- animal is completely blind, which is not consistent with the night-blindness 
phenotype in Oguchi Disease. It has been found that GRK7, an ortholog of GRK1, is expressed 
in the cones all mammalian species except murine animals. Therefore, GRK7 may have 
redundant function to GRK1 in phosphorylating cone opsin and preserving the cone vision in 
Oguchi Disease. The functionality of human GRK7 in mouse cones is verified in MCV7, MCV8 
and MCV78 animals in GRK1-/- background. The replacement of GRK7 over GRK1 in mouse 
cones restores the cone-derived B wave response, which supports that human GRK7 can 
phosphorylate and deactivate cone opsin. This is expected as many species such as fish and other 
vertebrates also express GRK7 in their cones; hence sometimes GRK7 is referred to as “opsin 
kinase”. Furthermore, the functionality of GRK7 in mouse cones confirms the mechanism in 
which Oguchi patients retain their cone function to prevent complete blindness. The cone 
response amplitude from MCV7-/- is 72% 105µV145µV
⎛
⎝⎜
⎞
⎠⎟
 to the response from MCV8-/-. This is due to 
the difference in the number of cones that have GRK7 expression between MCV7 and MCV8. 
With decreased S cones in the superior hemisphere of mouse retina, the GRK7 expression is 
correspondingly less in the superior region in MCV7. On the other hand, M cones are 
homogenously distributed in mouse retina to drive GRK7 expression in most of the cones. In 
fact, the ratio of GRK7-expressing cones between MCV7 and MCV8 is 74% 0.35 + 0.960.88 + 0.88
⎛
⎝⎜
⎞
⎠⎟ , 
which corresponds closely to the ratio of the B wave response amplitude between MCV7-/- and 
MCV8-/- animals. This calculation suggests that cone response amplitude is proportional to the 
number of GRK7-expressing cones in mouse retina. Furthermore, the response amplitude does 
not increase in the MCV78-/- cones because all the cones already have GRK7 expression from 
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the MCV8 transgene. The expression and response profile of MCV7 and MCV8 confirm that all 
cones have M opsin promoter activity, whereas S opsin promoter activity is higher in the inferior 
than superior hemisphere. However, the response amplitude in the MCV8-/- or MCV78-/- is not 
restored to the WT level. It has been shown that GRK1-/- photoreceptors have shortened rods and 
leads to reduced A wave response. The shortened photoreceptor OS may cause the reduction in B 
wave response by changing the glutamate release at the cone synaptic terminals. It is also 
possible that in GRK1-/- background, the constant R* activation in rod photoreceptor dampens 
the cone responses through electrical communication by the gap junction. By putting back GRK1 
in the rods of MCV78-/- animals to prevent ROS shortening, cone recordings can then be 
obtained to determine whether GRK7 can fully restore the cone-derived B wave responses.  
The function consequences of the five GRK1 mutants are studied in ectopic expression 
and in transgenic mouse models. In cells culture, the mutant expression profiles are different 
between insect and mammalian cell lines, where some of the mutants (K216R, P388H and 
V380D) are stably expressed in insect cells but become destabilized in mammalian cells. The 
change in protein stability can be attributed to the different degradation machinery between the 
cell types. As mammalian cultures are closely related to the mammalian in-vivo environment, the 
reduced expression suggests that these mutations destabilize GRK1. Interestingly, the decreased 
protein expression in the kinase-dead mutant, K216R, is opposite from the reported literature, 
where other groups are able to observe the mutant expression. Closer inspection on the technical 
details points to a difference in the expression time. Other groups have expressed the mutant 
upward of 48-72 hours, where in this study the transfected cells are harvested at 24 hours. At 
longer expression time, the mammalian cells may have reached stationary phase of growth and 
the degradation machinery may have shut down, masking the instability of the mutant protein. At 
earlier time points (<24 hours), it is evident that the stability of GRK1 requires the kinase 
activity. Nonetheless, ectopic expression of mutant proteins has to be carefully interpreted, as the 
cultured cell environment may not reflect the native conditions. 
To study the role of autophosphorylation on GRK1 function, we have generated the 
A4102 antibody to monitor the autophosphorylation level and the intrinsic kinase activity. GRK1 
autophosphorylation changes significantly in the first 30 minutes of dark-adaptation, suggesting 
its role in modulating GRK1 activity during light transitions. To further examine the 
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physiological role of GRK1 autophosphorylation, the STAA mutations are introduced into 
GRK1 to abolish the autophosphorylation sites. In insect cells, the STAA mutant is stably 
expressed but not autophosphorylated, further confirming the specificity of A4102 antibody. As 
expected, autophosphorylation requires the intrinsic kinase residue as no phosphorylation is 
detected in insect cells with K216R mutant expression. Although the expression profile of these 
two mutants changes when expressed in mammalian cell lines, several points can still be 
concluded from the mammalian culture study. First, GRK1 may require kinase activity for 
protein stability as GRK1 expression is abolished with K216R mutation. Second, 
autophosphorylation by the intrinsic catalytic activity provides for partial GRK1 stability as 
STAA mutation reduces GRK1 expression by ~50%. Other phosphorylation sites in GRK1 may 
be present to stabilize the protein, or the catalytic residue may have non-kinase role in the 
structural stability of GRK1. To further examine the role of the K216R and STAA mutations on 
GRK1 function, transgenic mouse lines are generated to express these mutants in mouse rods 
with the rhodopsin promoter. However, the characterization of K216R and STAA transgenic 
lines are met with several obstacles. The expression of GRK1 harboring K216R and STAA 
mutations is low despite the presence of transgene RNA, suggesting that kinase activity plays a 
role in GRK1 stability. To quantify the instability effects of GRK1 mutants, the ratio protein 
expression and RNA expression is compared between WT and GRK1 mutants. However, after 
several experimentations (data not shown), the RNA level in WT GRK1 and transgenic GRK1 
mutant are found to be very different. The differences in RNA level can be attributed to the 
promoters that drive GRK1 expression. WT mouse GRK1 is under the endogenous GRK1 
promoter, whereas rhodopsin promoter drives the expression of bovine GRK1 mutants. In fact, 
the mRNA level under the rhodopsin promoter is extremely low compared to mouse GRK1 
promoter. Due to this difficulty, the quantification of protein to RNA ratio is terminated in 
K216R and STAA transgenic lines. Furthermore, the transgenic expression of STAA mutant in 
mouse rods is low (15-23% compared to GRK+/- level) and displays a ‘mix-expression’ pattern in 
GRK1-/- background. The ‘mix-expression’, where some STAA+ animals have GRK1 expression 
while some do not, is one downfall in transgenic mouse model when random integration 
produces two transgene integration sites where one region is genetically silenced and the other 
one is active. Due to the low/no expression and ‘mix-expression’ of GRK1, the characterization 
of K216R and STAA transgenic mouse lines is currently discontinued. 
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Next, the effects of Oguchi mutations, P388H and V380D, on GRK1 function are 
investigated. When expressed in insect cells, both mutants affect the catalytic efficiency as 
demonstrated by the loss of autophosphorylation. In COS7 and HEK293 cells, mutant kinase 
expression is highly reduced, similar to the kinase-dead mutant. Sequence alignment shows that 
P388 is a conserved residue cross all GRK members in the catalytic domain, implying that it is 
important in GRK1 kinase activity. V380 is unique to GRK1, whereas other GRK members have 
a cysteine residue in the same location. While this residue is not conserved for GRK1, the 
introduction of a negatively charged residue into the catalytic domain by the V380D mutation 
may affect its kinase domain. The downregulation of GRK1 expression in the V380D mutant is 
consistent with published results. On the other hand, this is the first evidence demonstrating that 
P388H mutation causes GRK1 instability. The in-vivo effects of P388H and V380D mutations 
are assessed in transgenic mouse models. When crossed into GRK1-/- background, no GRK1 
protein expression is detected from the P388H transgene, despite high RNA level. In P388H 
animals, similar to K216R and STAA strains, the protein to RNA ratio is hard to determine and 
its characterization is terminated. It remains a possibility that the P388H mutation results in 
GRK1 instability and degradation, causing the rod recovery defect and the night-blindness 
phenotype in Oguchi Disease. 
Previous study by (Khani, Nielsen et al. 1998)) has demonstrated that V380D expression 
in COS7 cell is highly reduced and the mutant protein is unable to phosphorylation R* in 
purified ROS preparation. To our surprise, V380D expression in transgenic mouse rods is 
expressed and is catalytically active. The V380D transgenic animals express the mutant GRK1 
protein homogenously at 40% of the WT level. However, the autophosphorylation of V380D 
GRK1 is reduced to 20% when normalized to total GRK1 protein. Taken together, only 8% of 
the V380D mutant is catalytically active when compared to the WT level. These evidences 
confirm that GRK1 harboring V380D mutation remains catalytic active, although at reduced 
capacity. In addition, the low mutant expression can prevent and rescue the degeneration caused 
by the loss of GRK1. This observation provides an explanation on how human photoreceptors in 
Oguchi Disease remain viable and does not degenerate in the manner seen in mouse GRK1-/- 
photoreceptor. Interestingly, the catalytically active kinases (autophosphorylated GRK1) in 
V380D photoreceptor are detected only in the ROS, whereas the defective GRK1 
(unphosphorylated GRK1) is distributed throughout the photoreceptor. The residual mutant 
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GRK1 in ROS also functions in the light-dependent phosphorylation of R*, contrary to the 
published data described above. This difference is most likely due to the different protein 
regulation between COS7 cell and mammalian photoreceptor. Further physiological comparison 
demonstrates that WT and V380D animals have similar ERG responses, confirming that V380D 
photoreceptors can respond properly in fully dark-adapted state. As expected from the reduced 
activity and expression in V380D animals, the recover of rod photoreceptor is delayed compared 
to WT. In dim flash, the recover of V380D photoreceptor is delayed by ~3.75 fold, whereas in 
bright flash, the delay is only ~1.5 fold. The delay is more pronounced in dim flash condition 
because the regulation of GRK1 by recoverin. Under dim flash condition, the Ca2+ change is 
minimal and GRK1 remains associated to recoverin. As there are only 8% active GRK1 in 
V380D rods, the ratio of recoverin to the mutant GRK1 is greater than the WT level. Therefore, 
recoverin sequesters most of the V380D GRK1 and the free GRK1 concentration is likely very 
low, resulting in a longer recovery delay than bright light, in which recoverin releases all of the 
GRK1 protein when Ca2+ is low. The reduced expression and activity in V380D mutant cause 
rod recovery to be delayed up to one second in fully dark-adapted condition, however, the dark-
adaptation time (light to dark transition) in Oguchi patients is prolonged to greater than three 
hours. It is possible that single cell recording may not properly demonstrate the full recovery 
defect in V380D rods. To test the dark-adaptation ability in mouse, the time required for 
photoreceptors to recover from 50% bleached rhodopsin is measured. After light exposure for 
two minutes, WT animals can fully dark-adapt by 10 minutes, whereas V380D animals need 
more than one hour to recovery. Further extrapolation from this data suggests that if rhodopsin is 
bleached close to 100%, V380D can take more than two hours to fully dark-adapted, which is 
similar to the recovery defects documented in human Oguchi patients. In addition, a similar dark-
adaptation delay is recorded from Bark7 animals, which have ~15% GRK1 expression (Chen, 
Woodruff et al. 2010). This confirms that reduced GRK1 expression lead to delay in rhodopsin 
deactivation when the R* to kinase ratio is increased. When GRK1 level is reduced and becomes 
limited, the kinase cannot keep up with the demand of R* phosphorylation when a large amount 
of R* are generated, which results in dark-adaptation defect. Biochemically, V380D has reduced 
activity but can still function in rhodopsin phosphorylation and main a healthy photoreceptor. 
Physiologically, reduce V380D mutant expression causes rod recovery delay and dark-adaptation 
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defects. Together, these evidences provide a new mechanism in the pathogenicity of human 
Oguchi Disease.  
Lastly, the GRK1 harboring C558S mutation is the only mutant that has consistent 
expression in all the cell types tested. In-vitro data has demonstrated that isoprenylation is 
required for GRK1 to localize to the membrane and deactivate R* (Inglese, Glickman et al. 
1992). Isoprenylation is a PTM unique to the GRK1-family including GRK1 and GRK7, 
whereas other GRK members use other mechanisms for membrane association. For example, 
GRK2 associates with Gβγ to localize to the membrane (Ribas, Penela et al. 2007). To confirm 
the role of GRK1 isoprenylation in photoreceptor function, GRK1 with C558S mutation is 
expressed in mouse rod photoreceptors and studied in GRK1-/- background. While the protein 
distribution of C558S mutant is not homogenous in mouse retina, the transgenic mouse line is 
still useful for studying GRK1 isoprenylation. The C558S GRK1 is expressed at 82% compared 
to WT level and its autophosphorylation is reduced to 21% compared to total GRK1 level, which 
suggests that the lipid modification is not required for GRK1 activity. However, the reduced 
autophosphorylation in C558S mutant implies that full activation of the kinase requires 
isoprenylation and/or membrane association. In addition, GRK1 without isoprenylation is 
detected in the cytosol and is redistributed throughout the rod photoreceptor. Furthermore, 
C558S mutant is unable to associate with the lipid membrane and cannot be transported to ROS. 
Functionally, since GRK1 without isoprenylation cannot be targeted to ROS, the mutant kinase 
cannot deactivate R* during recovery and the C558S rods behaves similarly to the ones in 
GRK1-/- animals. These data confirm that isoprenylation is required for GRK1 to associate with 
the membrane and be targeted to the OS. Since GRK1 without isoprenylation is absent from the 
OS, the kinase cannot phosphorylate and terminate R* even though the mutant remains 
catalytically active. 
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Conclusion 
It is evident that any conclusions drawn from ectopic expression studies must be analyzed 
with careful consideration. Variations in cell regulation and signaling mechanisms may influence 
the phenotype observed across different cell types. The conclusions from cell culture 
experiments must be verified in native tissues. As GRK1 is responsible for light-dependent 
rhodopsin phosphorylation and the timely R* deactivation in phototransduction recovery, 
understanding the molecular details of GRK1 function is essential as changes in GRK1 activity 
has significant consequences on photoreceptor recovery. Five transgenic mouse lines are 
generated to study the consequences of the mutations, P388H, K216R, C558S, V380D, and 
STAA, on GRK1 function in photoreceptors. Due to technical issues derived from transgenesis, 
such as mixed expression, low/no protein and RNA expression, the characterization of P388H, 
K216R and STAA transgenic lines are discontinued. However, the preliminary work in this 
thesis suggests that P388H, K216R and STAA mutations play a role in GRK1 stability. 
In addition, through transgenic, biochemical, and physiological techniques, the 
mechanisms leading to the night-blinding Oguchi Disease are clearly described. Human GRK7 is 
functionally redundant to GRK1 and can preserve cone vision when GRK1 is defective in human 
Oguchi patients. Contrary to previous findings, GRK1 harboring V380D mutation has reduced 
expression and activity, and can still deactivate R* in a light-dependent manner and prevent the 
photoreceptor degeneration observed in GRK1-/- animals. In V380D animals, the reduced kinase 
activity causes a dark-adaptation delay, recapitulating the symptom observed in patients with 
Oguchi Disease.  
Last, the role of GRK1 isoprenylation in photoreceptor function is elucidated. The C558S 
mutation abolishes GRK1 isoprenylation. The mutant has normal, but patchy, GRK1 expression 
with reduced activity. Without isoprenylation, GRK1 cannot associate with the membrane nor 
target to the ROS. These data suggest that isoprenylation is required for full activation of the 
kinase, either by the lipid modification or the docking to the membrane near rhodopsin. Due to 
the lack of ROS targeting, photoreceptor with non-isoprenylated GRK1 behaves like GRK1-/- 
photoreceptor and has severe delay in recovery. Isoprenylation is an essential modification that 
allows GRK1 to localize to the outer segment and exert its function in rhodopsin deactivation.  
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CHAPTER 4 
Future Directions 
It is determined that rod and cone share the similar RLS in photoreceptor recovery, as the 
GTP-hydrolysis of transducin/cone transducin. As demonstrated in this thesis, studying cone 
phototransduction is more difficult due to the rarity and fragility of cones in mouse retina. To 
further understand how each phototransduction player contributes to the different response 
kinetics between rod and cone, the cone components can be swapped into rod photoreceptor 
using genetic manipulations with knock-in, knockout and/or transgenic constructs. Recent study 
(Chen, Woodruff et al. 2010) expressing cone transducin in rod photoreceptor without rod 
transducin has demonstrated that the Gα subunit contribute partially to the differences in the 
sensitivity, amplification, and recovery kinetics between rod and cone. Therefore, it is essential 
to swap the opsins, Gβγ subunits, and the CNG subunits between rod and cones to further 
understand the underlying factors on what makes rod a rod and cone a cone.  
As demonstrated by the degeneration observed in cones with high level of RGS9-1, 
photoreceptors are high susceptible to molecular or metabolic changes which can trigger cell 
programmed death. Understanding photoreceptor degeneration is an essential frontier in vision 
biology as 1 in 2000 people is estimated to suffer some forms of retinal degenerative diseases 
(Sohocki, Daiger et al. 2001), especially when there is a lack of therapy. While many 
degeneration models have been observed and documented in mouse and human, the molecular 
mechanisms leading to cell death remain elusive. Future investigation is required to monitor the 
pro-apoptotic pathways during photoreceptor degeneration and determine therapeutic methods in 
preventing or delaying cell apoptosis.  
Lastly, the findings from V380D and MCV78 animals provide a new mechanism in the 
pathogenesis of Oguchi Disease and confirm the role of GRK7 in preserving cone functions. 
Also, the role of isoprenylation in GRK1 membrane translocation is confirmed in mouse rods. 
These results increase our understanding on the structure-function relationship of GRK1. As 
mentioned, the P388H, K216R and STAA mutations require further investigation. To facilitate 
the characterization of GRK1 mutations, knock-in constructs can be used to introduce the 
mutations in mouse and to study the mutants under the same regulatory elements as WT GRK1. 
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Future characterization of P388H can reveal the mechanism on how the mutation causes Oguchi 
Disease. Similarly, studying the STAA mutant can demonstrate how autophosphorylation 
influences the function and stability of GRK1. Also, as we have established GRK7-expressing 
cones in MCV7 and MCV8, any functional variations between GRK1 and GRK7 can be studied 
through biochemical and physiological techniques.  
Through the use of genetic, biochemical, and physiological techniques, we have 
confirmed that cone transducin deactivation is the RLS in cone recovery. Also, a modified 
disease mechanism in human Oguchi patients is described in detail and further demonstrates the 
importance of timely opsin termination for normal vision. As we continue to study the rod/cone 
differences, photoreceptor degeneration, and the molecular details of phototransduction, one day 
we will have a complete understanding in photoreceptor biology and be able to prevent retinal 
diseases. 
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